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ABSTRACT
Bone tissue serves many functions, including structural support, protection of internal
organs, and mineral and growth factor storage, to name a few. Moreover, human bone exhibits
excellent mechanical properties, demonstrating superb compressive strength as well as
significant elasticity, due to its collagen content. However, defects still occur at a relatively high
rate in this tissue. Critical sized defects in bone are defined as defects that cannot form a union
and heal on their own. These types of defects occur often, and typically require surgical
intervention. The current gold standard treatment for critical sized defects in bone is the use of
allografts and autografts. There are many issues associated with these methods, including donor
site morbidity and the need for two surgeries. Recently, bone tissue engineering has emerged as
a future alternative to bone grafting for treatment of long bone defects. Numerous strategies
involving three basic components, biomolecules, stem cells, and engineered scaffolds, have
shown promise in inducing sufficient bone regeneration. However, a common limitation of these
strategies lies in their inability to generate bone tissue that mimics the organized microstructure
of cortical bone. For this reason, the regenerated bone is often highly disorganized and possesses
poor mechanical properties.
A relatively new concept in the field of tissue engineering is the concept of biomimicry.
This approach aims to create a scaffold that mimics the natural tissue as closely as possible,
including reproducing properties such as composition and microstructure. For bone tissue
engineering, specifically, this most often achieved by fabricating highly porous ceramic
constructs that resemble the structure of cancellous bone. These scaffolds have many excellent
qualities including bioactivity, space for cells and new tissue ingrowth, and relatively decent
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mechanical properties. However, when utilizing these scaffolds, new tissue is often very
disorganized and has poor mechanical properties.
Another biomimetic approach for bone tissue engineering, though not as popular, is to
utilize nanofibers to mimic the cortical component of long bones. Aligned polymer nanofibril
arrays are often used in tissue engineering applications due to their ability to mimic the aligned
extracellular matrix of numerous tissues in the body, including bone. The hypothesis of this
approach is that if a more organized bone structure is formed during the healing process, the time
for the remodeling process to occur would be reduced. This is advantageous as it will allow cells
to penetrate and migrate within the scaffold in order to regenerate the tissue. Aligned nanofibril
arrays can easily be fabricated using a basic electrospinning device and a modified collection
plate. This method does have a variety of advantages, including the ability to vary polymer types
and tailor the degradation rate. However, this method isn’t often utilized for bone tissue
engineering due to the extremely poor mechanical properties of polymer nanofibers. Some
researchers have investigated their use for bone tissue engineering, mineralized the surface of
nanofibers to more closely mimic the structure while enhancing the bioactivity, though this does
not help much with the mechanical properties.
To our knowledge, these approaches have not been used simultaneously in order to create
a truly biomimetic construct that mimics the entire structure of the human long bone. Thus, the
objective of this project was to optimize both of these techniques and then combine them in order
to fabricate a bone tissue engineering construct that mimics the whole structure of human long
bone. The first step was to create highly porous ceramic constructs that would mimic the
structure of human cancellous bone. We did this by creating a composite structure composed of
iii

both hydroxyapatite and beta tricalcium phosphate. Using varying concentrations of both
components, we were able to come up with a structure that suited our application. We then
aimed to mimic the structure and arrangement of collagen fibrils in cortical bones’ extracellular
matrix by using a customized electrospinning apparatus that is paired with motorized collecting
device developed in our lab, in order to spin small diameter, highly-aligned, loose nanofibril
arrays. To further mimic the structure of cortical bone, we created a novel hydroxyapatite coating
on the nanofibers surface to emulate the distinct relationship between collagen and
hydroxyapatite in native bone. We then combined both structures in order to create a truly
biomimetic long bone tissue engineering scaffold. These scaffolds were evaluated both
separately and together in vitro for bone regeneration capabilities. Future studies include in vivo
implantation into rabbit radial defects to assess regeneration and organization of new bone tissue.
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CHAPTER 1
INTRODUCTION

1.1 Background
The main objective of this research is to address the major challenges related to the repair of
critical sized defects in bone. Current methods, which are based on the use of autografts and
allografts, possess many inadequacies, including lack of donor tissue, donor site morbidity, and
infection. This problem is increasingly relevant, as these types of defects are occurring at an
alarming rate. Though tissue engineering strategies are being investigated to overcome some of
these limitations, others issues become apparent. The most evident issue related to these
approaches is the regeneration of a highly disorganized bone tissue. This disorganized bone is
characterized by the quick, haphazard organization of collagen fibers and is mechanically weak.
Human long bone consists of two major components, namely cancellous and cortical bone.
Though these components have similar compositions, they possess different structural and
functional properties. The cortical bone forms a dense outer shell surrounding the highly porous
cancellous bone and provides bone with its excellent mechanical properties. Our approach
focuses on the fabrication of a bone tissue engineering scaffold that closely mimics this distinct
structure of human long bone. This approach is based on the principle of biomimicry, which
implies structural, compositional, property, and functional similarities to the natural tissue. Our
first objective was to mimic each component of long bone individually before creating a
composite structure that truly mimicked the complete structure. In creating this type of structure,
our hypothesis is that a more organized bone tissue will regenerate. This hypothesis is based on
the widely known fact that cells are guided by chemical, mechanical, and structural cues
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provided by tissue engineering scaffolds. Further, newly secreted extracellular matrix (ECM)
will also be guided by these scaffolds, further validating this hypothesis.
The following chapters will describe in depth the procedures and methods used to fabricate
the biomimetic composite bone tissue engineering scaffold. Briefly, we first expanded the uses
of unidirectional aligned nanofibrous arrays in order to guide new tissue ingrowth for cortical
bone tissue regeneration. We then fabricated porous ceramic structures with well-controlled
pore size, distribution, and connectivity to further enhance cancellous bone tissue regeneration.
Finally, we combined both constituents into a human long bone-like configuration and conducted
some preliminary in vitro tests to assess new tissue ingrowth and organization. In the future, we
plan to conduct in vivo tests in rabbit radial critical sized defects in order to assess new bone
formation and organization.
The significance of this research is highly apparent, as we are hoping to fill in the gaps of
bone tissue engineering research. Discovering a method to more effectively regenerate an
organized bone tissue has huge implications for the treatment of critical sized bone defects.
Tissue engineering is still considered a future alternative for this type of treatment, but if this
approach can be perfected, it will quickly replace the current gold standard, which is attributed
with many complications. The approach described above is innovative in the regard that no
other researchers have attempted to create a composite structure that mimics both components of
human long bone. This research is markedly different than any other type of investigation for
bone tissue regeneration as our goal is not to regenerate bone tissue, but to regenerate organized
bone tissue. We believe the chemical and structural cues provided by our biomimetic scaffold
will facilitate in accomplishing this goal.

2

1.2 Study Objectives and Aims
The objective of this research is to create a truly biomimetic scaffold for bone tissue
regeneration to more efficiently and effectively regenerate this tissue. To this end, we aimed to
create a scaffold that mimicked both the cortical and cancellous components of long bone. In
doing so, we believe that newly secreted bone tissue will initially organize into a microstructure
more similar to that of natural bone tissue, therefore reducing healing time.

The scientific impact of this work is the ability to recruit endogenous stem cells to a truly
biomimetic scaffold in order to regenerate a bone tissue that is more similar in microstructure to
natural bone. Doing so would diminish the need for autografts, which possess numerous
shortcomings. Accordingly, three specific aims are proposed:

Specific Aim #1: To fabricate highly-aligned, mineralized nanofibrous arrays to serve as
scaffolds for cortical bone regeneration applications.
Rationale: Our preliminary data indicates, and many others have shown, that newly
secreted extracellular matrix (ECM) is guided by scaffold and cell morphology. For cortical
bone tissue, this implies a highly organized aligned structure. For this reason, we aim to create
highly-aligned nanofibrous arrays utilizing a novel electrospinning device, and mineralize these
scaffolds using a biomimetic process. By mimicking the structure and composition of this tissue,
we believe we will be able to regenerate a more natural tissue that has a similar structure to the
original tissue and possesses enhanced mechanical properties.
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Specific Aim #2: To fabricate highly porous ceramic constructs to serve as scaffolds for
cancellous bone regeneration applications.
Rationale: Highly-porous ceramic scaffolds have been used extensively in bone tissue
engineering applications. This is true as they possess multiple beneficial properties for this
application, including similar composition, high porosity, bioactivity, and excellent mechanical
properties.

The highly porous nature of these scaffolds allow for significant bone ingrowth

whereas their composition makes them inherently bioactive. These types of structures have been
demonstrated to enhance bone tissue regeneration both in vitro and in vivo.

Specific Aim #3: To fabricate a 3D, biomimetic, composite structure, which incorporates
highly-aligned, mineralized nanofibers as well as highly-porous HA/βTCP constructs, and
evaluate the bone regeneration ability in vitro by assessing cell attachment, migration,
morphology, viability, proliferation, differentiation, and new ECM secretion/organization.
Rationale: The use of in vitro studies has long been a reliable and efficient way to
predict behavior in vivo. By assessing certain factors, such as cell viability, proliferation,
differentiation, and new ECM production in vitro, it will be more possible to determine the
efficacy of these scaffolds as bone regeneration tools in vivo. Previous data has demonstrated
enhanced

migration,

viability,

proliferation,

differentiation,

and

ECM

secretion

of

osteoprogenitor cells when seeded on biomimetic scaffolds in vitro. Further, this method will
also be able to reveal whether or not the new ECM produced possesses the desired structure and
organization that is hypothesized to be produced.
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1.3 Organization of Dissertation
In this dissertation, part of this research was reported. Chapter 2 gives an overview of the
background for this work, beginning with a description of human bone structure, composition,
and properties. We further discuss bone defects, as well as current treatment methods for critical
sized defects in bone. We then go into an in depth review of tissue engineering strategies, to
date, including current biomimetic methods and approaches being utilized. This section will
specifically highlight the use of functionalized nanofibers for cortical bone regeneration, as well
as the use of highly porous ceramic scaffolds for cancellous bone regeneration.
Chapter 3 and 4 were focused on fabricating biomimic scaffolds utilizing nanofibers and
microfiber arrays for cortical bone regeneration. Chapter 3 highlights our novel method for
fabricating and functionalizing nanofibrous scaffolds in order to mimic the aligned collagen and
embedded hydroxyapatite in cortical bone. We characterize these scaffolds in depth as well as
present some preliminary in vitro data highlighting their ability to promote bone regeneration.
Chapter 4 is complemental to this work and explored the beneficial effect of added surface area
as well as contact guidance cues provided by these atypically shaped microscale fibers. The
novel idea of utilizing star-shaped microfibers for tissue engineering applications is discussed in
depth. Our hypothesis is that the extremely high surface area of these fibers would allow for
excellent cell attachment and proliferation. Further, we explored the idea that the contact
guidance that may be offered by these fibers would have a beneficial effect on osteoblast
behavior. These fibers were fabricated using a custom designed extrusion device designed in our
lab. They were characterized in depth, including surface area calculations, and some preliminary
cell attachment and proliferation studies were conducted. Future plans of incorporating these
fibers into 3D biomimetic bone tissue engineering constructs were also discussed.
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Chapter 5 was devoted to cancellous bone regeneration using porous ceramic scaffolds.
There is a wealth of knowledge in the literature dealing with this topic, demonstrating bone
regeneration capabilities both in vitro and in vivo. However, we aimed to further enhance this
effect by altering the composition and enhancing the porosity. The structure and composition of
these scaffolds mimicked the properties of cancellous bone. These scaffolds were characterized
in depth, including structural, mechanical, and degradation properties. Preliminary in vitro
experiments were also conducted in order to assess cell attachment and infiltration with the
scaffolds as well as cell viability and proliferation.
In Chapter 6, we combined the highly-aligned, mineralized nanofibrous scaffolds and
highly porous ceramic constructs in order to fabricate a truly biomimetic 3D composite scaffold
that mimics the entire structure of a human long bone. These scaffolds were characterized in
depth and evaluated in vitro in order to assess newly formed bone organization.
At the end of this thesis (Chapter 7), overall conclusions of our work were described. We
will discuss major challenges associated with this work as well as go into depth about future
directions for this project, including growth factor incorporation as well as upcoming in vivo
experiments in rabbit radial defects.
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CHAPTER 2
BIOMIMETIC SCAFFOLDS FOR BONE TISSUE ENGINEERING: A LITERATURE
REVIEW
2.1 Bone Structure and Composition
The intricate structure of bone is considered an engineering marvel, boasting exceptional
mechanical properties while possessing minimal mass. This tissue is composed of both organic
and inorganic components, with the inorganic hydroxyapatite (HA) forming between and
elongating on the aligned organic collagen fibers. This structure is the building unit and lowest
level in the hierarchical structural organization of bone. The combined composition of both
collagen and hydroxyapatite allow for extraordinary strength, while also allowing a degree of
elasticity that is necessary to absorb shock and displace loads. This structure and composition
allows bone to perform its main structural functions, providing support and protection, while still
allowing other functions, such as mineral ion homeostasis, growth factor storage, and red blood
cell manufacture, to take place.
The macrostructure consists of both cortical and cancellous bone, with each of these
types of bone having a very distinct microstructure. Whereas cancellous bone has a very
irregular and porous microstructure, cortical bone’s microstructure is very ordered and is
composed of very tightly packed osteons, also called haversian systems. These osteons are
cylindrical structures that consist of lamellar sheets of aligned collagen fibers formed into
concentric layers. Lower in the hierarchical structure of bone, these fibers are composed of
aligned fibrils, which are self-assembled from triple-helical collagen molecules. These
molecules are staggered in their long axis by 67 nm, generating a 35 nm anionic gap zone in
which HA is nucleated (Figure 2.1A) [1, 2]. The size of these HA crystals range from 2 to 7 nm
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in thickness, 15 to 200 nm in length, and 10 to 80 nm in length [2, 3]. Once nucleated, these
crystals align and elongate along with the aligned collagen fibrils (Figure 2.1B). The HA
component in this precise nanostructure allows for enhanced mechanical properties that give
bone its necessary high strength and fracture toughness. Yet, the highly crosslinked collagen
framework maintains its load-bearing function, as well as viscoelasticity, which allows bone
tissue to absorb shock [4]. This structure, however, also plays a significant role in cell behavior
and response. While osteoblasts and osteoclasts are present on the mineralized bone, osteocytes
are embedded within the bone matrix. Specific cues and signals between the different cells,
allows for ECM secretion/resorption as well as mineralization of this matrix. The collagen
matrix, which is secreted by the osteoblasts, provides a substrate for the HA to deposit as well as
for the bone forming cells to attach, align, and proliferate.

A

B

Figure 2.1: Microstructure of bone, showing staggered structure of collagen molecules, which
creates hole zones in which HA is nucleated (A) [1], the lowest level of hierarchical structure of
bone, showing alignment and elongation of HA crystals as a function of underlying aligned
collagen fibrils (B) [2] (Reproduced by permission of The Royal Society of Chemistry)
(http://dx.doi.org/10.1039/b402005g)
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2.2 Bone Types and Properties
There are many different types of bones, though, including long bones, such as the tibia
and femur, which have a cancellous interior and a dense cortical shell, and flat bones, such as the
calvaria, which have a sandwich structure with dense cortical layers on the outside and a thin
layer of cancellous bone on the inside [1]. While the components remain the same, each type of
bone has their different macrostructures in order to serve different functions. These functions
include structural support, protection, storing of healing cells, and mineral ion homeostasis [1].
The mechanical properties of bone also differ depending on the bone type, and can vary along
and throughout the bone, as well. Long bones, which consist of mostly cortical bone, have been
shown to have a yield strength of 78 to 151 MPa in tension, 131 to 224 MPa in compression, and
a modulus of elasticity of 17 to 20 GPa, when tested along its longitudinal axis. However,
cancellous bones’ mechanical properties are much lower, with its strength ranging from 5 to 10
MPa and modulus from 50 to 100 MPa [5-7]. This drastic change is due to the highly porous
structure of cancellous bone [8]. The amount of mineralization, which can vary between bones
and, more typically, bone types, also has a great effect on the mechanical properties of bone [9].
While mechanical properties of bone have often been described, they are usually expressed in a
range, since the actual numbers can vary from specimen to specimen, as well as change
depending on testing method and conditions [1]. Despite the superior mechanical properties
described above, defects still occur very often in bone tissue.

2.3 Bone Failure and Current Treatment Methods
Critical-sized defects in bone are highly prevalent in today’s society, due to trauma,
congenital deformity, or disease [10]. Trauma can occur due to many instances, including
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battlefield injuries [11, 12], gunshot wounds [13], or accidents, such as falling and breaking a
bone [14]. In about 5-10% of all traumatic bone injuries, bone cannot heal itself to form a union,
and surgical intervention must take place [10, 15]. The most prevailing type of congenital
deformity associated with bone that is seen today is a cleft palate [16, 17], in which, during
development, the palatal shelves that form the palate do not fuse [18]. Surgical resection of large
portions of bone also needs to be performed oftentimes due to diseases, such as cancer, with the
most prevailing type being osteosarcoma [19]. With this case, a large amount of bone typically
needs to be removed and replaced with a permanent prosthesis, if no other options exist.
However, these prosthesis often fail due to wear debris or deep infection over time [19].
Currently, autografts and allografts are the main treatment methods for critical-sized defects in
bone. However, issues associated with these methods are very common, as well, and include
donor site morbidity [20, 21] and donor to recipient related infections [22, 23]. For these
reasons, researchers have begun to steer more towards a tissue engineering approach in order to
actually regenerate bone tissue. This would allow for new tissue in-growth that would take place
while a temporary scaffold is degrading and would eventually replace it with the native tissue.
This method would only require one surgical procedure and would be a drastic improvement on
the methods currently being used.

2.4 Tissue Engineering for Bone Regeneration
Tissue engineering has been described as “an interdisciplinary field that applies the
principles of engineering and life sciences toward the development of biological substitutes that
restore, maintain, or improve tissue function or a whole organ” [24, 25]. The term tissue
engineering first became known in the early to mid 90s and since has become widespread and
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considered by many to be the primary means for repairing/replacing tissue/organ defects in the
future. The concept utilizes 3D scaffolds, cells, and growth factors/biomolecules (Figure 2.2)
[26] in order to provide a temporary tissue construct for cells to grow on and produce
extracellular matrix while new tissue forms and the scaffold degrades [27]. In theory, these
scaffolds should be biocompatible, degradable, highly porous, and hydrophilic, in order to allow
for cell infiltration and attachment, as well as tissue in-growth [27, 28]. Depending upon the
application, many other properties are also required, such as suitable elasticity and other
mechanical properties [27]. Specifically, the field of bone tissue engineering requires many of
the same properties as other tissue engineering areas for scaffold materials, including
biocompatibility, biodegradability, and high porosity, to name a few. Timely biodegradability
and high porosity are especially important in order to allow for bone ingrowth and
vascularization. Other requirements for bone tissue engineering scaffolds include: acting as
substrate for osteoid deposition, supporting and promoting osteogenic differentiation, and
promoting osseointegration [7]. Additional requirements can be seen in Table 2.1 [29].
However, since bone tissue is a type of load-bearing tissue, the scaffolds for bone regeneration
need to possess sufficient mechanical properties.
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Figure 2.2: Basic principles of tissue engineering [26]

After a suitable scaffold has been created for the desired application, cells can be
incorporated within these scaffolds in order to attach, proliferate and produce new tissue, which
will eventually take the place of the degraded scaffold. The type of cells used is extremely
extensive and depends on the application and the tissue being regenerated. The cells can either
be fully differentiated cells or progenitor cells, such as stem cells, that can be induced to
differentiate towards a certain lineage [30]. For example, specifically for bone tissue
engineering, osteoblasts can be seeded onto matrices and implanted in order to secrete new bone
tissue in order to regenerate injured bone. However, certain stem cells can also be used. These
cells can be directed to differentiate toward the desired lineage in order to regenerate the injured
tissue. These types of cells, which can be of embryonic or adult origin, are often easier to use
because one type of stem cell can be differentiated towards multiple cell lineages and be used for
several applications. Though embryonic stem cells are useful due to their inherent ability to
produce all cell lineages, adult stem cells are frequently used since there is no ethical
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considerations plus, they are usually very easy to acquire non-invasively. Such examples include
adipose-derived stem cells (ADSCs) and dental pulp stem cells (DPSCs), which can be acquired
from excess fat tissue or extruded molars/wisdom teeth, respectively. Both of these cell types
have been shown to be multipotent, or be able to differentiate into multiples cell lineage
pathways, including osteogenic pathways [31, 32]. There are many other stem cells that are
capable of osteogenic differentiation, including mesenchymal stem cells (MSCs), a type of
multipotent stem cells. MSCs are originally found in bone marrow, however, they may be
isolated from many other tissue sources as well (Table 2.2) [33]. As can be seen from Table
2.2, regardless of the tissue source, MSCs generally have osteogenic potential. In order to induce
differentiation of these cells towards a desired lineage, such as an osteogenic lineage for bone
tissue regeneration, the tissue engineering scaffolds can be loaded with growth factors or other
biomolecules. This can be done by either incorporating them within the polymer scaffold or
chemically attaching the biomolecules to the surface [34-36]. However, it is important to note
that cell-free strategies are also prevalent for tissue engineering applications. These scaffolds
don’t involve the inclusion of any cells on the scaffold, but feature growth factors and other
biomolecules either attached on the surface of the polymer or incorporated within the scaffold.
The incorporated growth factors will be controlled released from the scaffold and may recruit
endogenous stem cells and induce them to differentiate into a desired lineage in order to
regenerate the injured tissue [37].
To this end, the concept of biomimicry has recently evolved to define the properties of
scaffolds for bone regeneration. Biomimicry refers to structural, compositional, property, and
functional similarities of an artificial structure to a natural tissue. Using an artificial structure that
is both physically and chemically biomimetic, it is more possible for the body to regenerate a
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tissue in a manner that would occur naturally. As it is widely known that cells are guided by
chemical, mechanical, and structural cues, this principle has some credibility. Newly secreted
extracellular matrix (ECM) will also be guided by these scaffolds, further validating this theory.
For this reason, biomimicry has been extensively used as a criterion to direct material choices
and scaffold design for bone regeneration. Many factors need to be considered when designing a
biomimetic bone tissue engineering scaffold, including extent of mimicry, biocompatibility,
biodegradability, mechanical properties, osteoconductivity, porosity, and growth factor
incorporation, to name a few. When considering these factors, it is impossible to design a
scaffold that possesses every single one of these qualities. The objective is to create a good
balance of all of these qualities in order to produce a scaffold that most effectively regenerates
the tissue
Many different materials have been investigated for uses in biomimetic bone scaffolds.
The most obvious choice would be ceramics, due to their similar composition to natural bone.
Ceramics have also been proven to have enhanced bioactivity, by bonding to bone easily and
enhancing bone tissue formation. However, for tissue engineering applications, these materials
are not suitable due to increased brittleness when creating a porous scaffold, as well as lack of
biodegradability and osteoinductivity. This has led investigators to look more towards polymers
as materials for synthetic bone scaffolds. They are great for tissue engineering applications due
to their biocompatibility, biodegradibilty, and versatility. However, these materials lack the
mechanical properties to act as bone tissue substitutes. Recently, however, polymer/ceramic
composites have emerged as the leading method for developing synthetic bone scaffolds [7] in
order to take advantage of the superior qualities of both materials. These scaffolds are created
by incorporating nano-size ceramic constituents, such as HA, into polymer matrices, thus
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creating a biomimetic structure as well as improving mechanical properties. These composite
structures have been shown to improve tensile strength, modulus, and crack resistance [7, 38-41].

Table 2.1: Desirable qualities of a bone tissue-engineering scaffold [29]

Table 2.2: Sources of adult mesenchymal stem cells (MSCs) [33]
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2.5 Scaffold Fabrication Techniques for Cortical Bone Tissue Engineering
There are not many techniques discussed in the literature aimed specifically at
regenerating cortical bone tissue. Most approaches focus on regenerating bone as a whole and
utilized porous polymer or ceramic scaffolds. One method, however, that can be used to
specifically regenerate cortical bone is the use of electrospinning [42-47], which is due to its
unique ability to create polymer nanofibers that can mimic the ECM of many tissues, including
the lowest level in the hierarchical structure of cortical bone. Using this method, nanofibers have
been created that can be highly aligned and range from a few microns down to as small as
several nanometers in diameter. A wide variety of polymers can be used with electrospinning,
including synthetic, natural, or a combination of both. This allows the ability to tailor specific
properties, including mechanical properties and degradation rates. Further, these electrospun
scaffolds have the ability to be easily mineralized with hydroxyapatite using a biomimetic
technique. Available techniques for the mineralization of polymer fibers include electrospraying
[48], co-precipitation [49, 50], blending [45, 51-61], simulated body fluid (SBF) immersion [6265], and an alternate soaking process [66-70]. This would allow for a composite structure that
has a very similar microstructure to that of natural bone. In this case, benefits of both polymers
and ceramics can be utilized, while cutting down the drawbacks. Using just polymers would not
allow for a high mechanical strength, whereas using just ceramics provide a material that is too
brittle. Also, polymers that can be used to create these scaffolds are biodegradable, so they can
degrade over time in order to allow for new tissue infiltration. Further, the incorporation of
polymers supports cell adhesion, alignment and proliferation, whereas the incorporation of HA
allows for not only better mechanical properties, but bioactivity and osteoconductivity of the
scaffold, as well.
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It is highly evident that tissue engineering approaches for bone regeneration are necessary
in order to produce an effective strategy for bone growth/repair. Biomimetic approaches seem to
be the frontrunner when trying to achieve goals in this area. Concurrently, creating biomimetic
structures by mineralizing electrospun scaffolds, loading them with growth factors/biomolecules,
followed by creating 3D bone-like structures, represents a promising strategy for the
regeneration of native bone tissue. In the following section, we will review the electrospinning
technique and biomineralization techniques for the creation of polymer nanofibers array-based
biomimetic scaffolds for bone regeneration.

2.5.1 Electrospinning
Electrospinning is a tissue engineering technique that has been used for many years to
fabricate polymer nanofibrous scaffolds. It utilizes a high voltage power supply to electrically
charge a polymer solution that is then extruded from a syringe through a metallic capillary outlet,
using a syringe pump. The polymer droplet transforms into a Taylor cone due to the electrostatic
charges, and when the voltage surpasses a threshold value, the polymer solution becomes a
charged jet. This charged jet moves towards a metal collection plate, with the solvent
evaporating in the process, and polymer nanofibers remain on the collection plate [71] (Figure
2.3 for schematic). Nanofibers with diameters ranging from a couple microns down to a few
nanometers, which can be compared to the extracellular matrix of many tissues in the body, have
been created using this method.
Numerous physical traits of the scaffolds can be produced by varying the electrospinning
conditions and parameters. Changing parameters such as the polymer concentration, solvent,
voltage, flow rate, distance to the collection plate, and diameter of the needle, can drastically
alter the morphology of the fibers. Also, by changing how the fibers are collected, the
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morphology of the scaffold can be affected, either producing randomly aligned mats, highly
aligned scaffolds, or 3D structures [72]. These scaffolds are considered superior tissue
engineering scaffolds because they are highly porous and have a high surface area to volume
ratio [27, 73]. Electrospinning techniques are compatible with many types of polymers, natural
or synthetic, or combinations of both. Table 2.3 lists some common types of polymers that may
be electrospun. The ease of fabrication, and the low cost, plus the ability to tailor the scaffolds to
one’s specific needs, makes electrospinning an excellent candidate and popular choice for tissue
engineering applications.
It is highly evident that electrospinning has many excellent qualities, which have made it
one of the leading scaffold fabrication methods for tissue engineering applications, including
bone tissue engineering. Many different approaches for bone tissue regeneration are being
undertaken using this electrospinning technique. These approaches are typically designed to
mimic the natural structure of bones, and include: creating aligned nanofibrous scaffolds,
creating polymer/ceramic composites, biomolecule/drug encapsulation/delivery, and creating 3D
electrospun nanofiber-based biomimetic scaffolds. However, electrospinning can be considered
a biomimetic technique in itself. With electrospun nanofibers ranging from a couple of microns
down to several nanometers, these nanofibers mimic the collagen fibers found in bone’s
extracellular matrix. This similar morphology allows for superior mechanical properties, as well
as increased cell attachment and proliferation [64, 74-76]. This enhanced cell attachment can
most likely be attributed to the greater surface area provided by the 3D structure. Numerous
studies also indicate that cells seeded onto polymer nanofibers, as compared to smooth controls,
generally show enhanced ECM production [77, 78]. In a study by Chan et al [78], collagen
electrospun nanofibers scaffolds were shown to significantly increase cell attachment as
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compared to collagen films used as the control. This shows the great importance of surface
topography for cell attachment. This groups also compared other smooth materials to various
polymer nanofibers, and determined that cells attached significantly better to that nanofibers as
compared to the controls (Figure 2.4) [78]. Other groups have also conducted studies
comparing electrospun scaffold to tissue culture polystyrene (TCP) and have indicated enhanced
cell attachment, spreading, and proliferation, as well [74-76]. Further, theses scaffolds have also
been shown to stimulate prostaglandin synthesis, osteocalcin sythesis, and alkaline phoshatase
activity in osteoblastic cells, as well as show increased amount of collagen production and
calcium deposition [47, 75]. However, many researchers are now focusing on using
electrospinning combined with other biomimetic techniques, listed above, in order to more
completely mimic the actual structure and composition of bones’ microstructure. These
biomimetic methods are being tested in vitro using cell studies for attachment and proliferation,
measuring alkaline phosphatase (ALP) activity, ECM production, as well as in vivo for new bone
tissue formation. Mechanical testing is also being conducted in order to determine if mechanical
properties of the scaffolds are improved and are suitable for this application.

I
O

Figure 2.3: Schematic of a standard electrospinning setup
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Table 2.3: Common examples of synthetic and natural polymers, as well as a combination of
both, used for electrospinning
Po ly m e r
Syt h et ic
Poly(L-la ct id e)[9 4 -9 6 ]
Poly(ε-ca p r ola ct on e)[9 7 -9 9 ]
Poly(la ct id e-co-glycod id e)[1 0 0 -1 0 3 ]
Poly(eth ylen e oxid e)[9 9 , 1 0 4 ]
Poly(vin yl a lcoh ol)[1 0 5 , 1 0 6 ]
Poly(es t er u r eth a n e) u r ea [1 0 7 , 1 0 8 ]
Poly(eth ylen e-co-vin yl a lcoh ol)[1 0 9 ]
Poly(L-la ct id e-co-ε-ca p r ola ct on e)[1 1 0 , 1 1 1 ]
Na tu r a l
Ch it in [1 1 2 , 1 1 3 ]
Ch it os a n [1 1 2 -1 1 5 ]
Colla gen [1 1 6 -1 1 9 ]
Cellu los e[1 1 3 ]
Silk Fib r oin [8 0 , 1 2 0 , 1 2 1 ]
Hya lu r on ic Acid [1 1 3 , 1 2 2 ]
Fib r in [1 2 3 ]
Fib r in ogen [1 2 4 -1 2 6 ]
Gela t in [1 1 7 , 1 2 7 ]
E la s tin [1 1 6 , 1 1 7 , 1 1 9 ]
Com b in a t ion
Silk Fib r oin a n d Poly(et h ylen e oxid e)[1 2 8 ]
Hya lu r on ic Acid a n d Poly(ε-ca p r ola cton e)[1 2 9 ]
Colla gen a n d Poly(ε-ca p r ola ct on e)[1 3 0 , 1 3 1 ]
Ch it os a n a n d Poly(et h ylen e oxid e)[1 3 2 ]

Figure 2.4: 1: TCP, 2: glass coverslip, 3: gelatin-coated coverslip, 4: collagen-coated coverslip,
5: P(LLA-CL) nanofiber, 6: air-plasma treated P(LLA-CL) nanofiber, 7: Collagen-coated
P(LLA-CL) nanofiber, 8: collagen microfiber, 9: collagen nanofibers [78]
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2.5.2 Creating Aligned Nanofibrous Scaffolds
Aligned nanofibrous scaffolds, produced by electrospinning, have been gaining in
popularity in recent years due to their increased ability to mimic the aligned collagen fibers in the
extracellular matrix of many tissues of the body, including bone. This biomimetic method for
bone tissue regeneration applications allows for bone forming cells to attach and align along the
aligned fibers and has been shown to demonstrate enhanced proliferation and ECM production
[79, 80]. The main approach currently being utilized to create aligned nanofibers is by using a
rotating collecting drum. This metal collecting drum is connected to a high speed motor, so as it
rotates, the charged polymer solution travels towards it, and the fibers collect on it in an aligned
manner, in the tangential direction [51, 52, 77, 81-83]. This is a very simple and efficient way to
create aligned nanofibers (Figure 2.5). Lee et al. [79] used this rotating drum method and
observed cell orientation parallel to the aligned fibers whereas a random orientation was
observed for the cells seeded onto films and randomly oriented fibers (Figure 2.6A). They also
observed a significant increase in proliferation, when comparing the aligned fibers to the TCP
control, as well as ECM production, when comparing the aligned fibers to randomly oriented
fibers (Figures 2.6B and 2.6C, respectively). A significant increase was also seen in the
mechanical properties of the aligned scaffolds (Figure 2.6D) [79]. Similarly, Zhong et al. [80]
also saw a significant increase in cell proliferation in aligned scaffolds compared to randomly
oriented scaffolds. However, there are not many instances where aligned nanofibers have been
used specifically for bone regeneration applications. In a related application, Bashur et al. [77],
used this same method, and compared aligned scaffolds to unaligned scaffolds and spincoated
samples. It was determined that bone marrow stromal cells oriented parallel to the aligned fibers
and assumed a more spindle-like morphology on these scaffolds, whereas compared to the
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controls, no orientation was observed. It was also observed that, as compared to the unaligned
scaffolds, when cells were cultured on aligned nanofiber scaffolds, the relative expression of four
different ligament proteins was increased, though specific markers for bone tissue formation or
bone cell differentiation was not assessed. In another study, Jose et al. [51, 52], used this same
electrospinning method for bone tissue regeneration, but also incorporated HA nanoparticles into
the scaffolds. Preliminary studies have indicated greater mechanical properties, such as storage
modulus for the aligned composite scaffold containing an optimal concentration of HA, however,
these parameters were not compared to unaligned nanofibrous scaffolds as a control. Cell studies
do indicate, though, that these scaffolds support cell adhesion, spreading, proliferation, and
growth, and showed that the cells aligned along the direction of the fiber orientation.
Other techniques to attain highly aligned nanofibers are also employed, and are not quite
as popular, but oftentimes will demonstrate enhanced alignment of the nanofibers. These
techniques typically rely on two parallel collecting plates, in which the polymer solution is
extruded in between the two. Once a charge is applied to the polymer, it travels towards the
plates and the electric field between the two plates triggers the fibers to align parallel to each
other but perpendicular to the plates (Figure 2.7) [84, 85]. For instance, Li et al. [85, 86] used
this method to develop highly aligned scaffolds with over 80% of the fibers being at the 0º angle.
These results were determined by the measurement of over 150 fibers. No cell studies or
mechanical testing was conducted at this time, but the researchers introduced this technique as an
idea to create 3D structures with these aligned scaffolds for specific tissue engineering
applications. Beachley et al. [84] used a similar parallel plate approach, but developed a system
that utilizes parallel rotating plates (data not shown). Once the fibers align between the plates,
they are moved down to a collection rack at the bottom by these rotating plates. This allows for
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increased alignment, as well as the ability to tailor the scaffolds’ thickness/fiber density. In vitro
results indicate higher cell proliferation after 7 days of culture on aligned scaffolds as compared
to films. The cells were also observed to align parallel to the fiber direction, whereas a random
orientation was demonstrated by the cells on the films (paper in press). This method is beginning
to be utilized more often, and allows the ability to easily create highly aligned nanofibers, in
which the fiber length, diameter, and uniformity can be altered.
Though few cell studies justifying aligned nanofibrous scaffolds have been specifically
conducted for bone regeneration applications, preliminary data in other areas suggest that these
aligned nanofibrous scaffolds could potentially enhance bone tissue formation, and are thus good
candidates for bone tissue regeneration applications. With literature reporting that nanofibrous
scaffolds demonstrate enhanced attachment and proliferation as compared to smooth controls,
and aligned nanofibrous scaffold show enhanced ECM production and proliferation as compared
to unaligned nanofibers, it is obvious that these scaffolds are superior to others currently being
used for bone regeneration applications. With additional research in this area being focused
specifically for bone regeneration efforts, many new milestones can be achieved in this field. By
building on data previously reported in the literature, it will be possible in the future to
regenerate bone using aligned nanofibrous scaffolds.

Figure 2.5: Schematic of modified electrospinning setup utilizing a rotating drum [87]
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Figure 2.6: Cell alignment and ECM production on polyurethane films (top), aligned nanofibers
(middle), and randomly oriented nanofibers (bottom) (A), cell proliferation (B), collagen I
production (C), and mechanical properties aligned and randomly oriented scaffolds (D) [79]

A

I
O

Figure 2.7: Schematic of the parallel plates electrospinning setup (A), aligned
nanofibrous scaffold produced by this method (B)
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2.5.3 Creating Polymer/Ceramic Composites
For bone tissue engineering, the main method for creating a biomimetic structure most
often utilizes a polymer and ceramic composite in order to not only enhance mechanical
properties, but also create a more osteoconductive scaffold. This is due to the inherent ability of
the polymer/ceramic composite to mimic the mechanical and physical properties of the
microstructure of bone, which consists of HA nanoparticles forming between, and aligning on
the collagen fibers of bones’ extracellular matrix. This exquisite structure permits extraordinary
mechanical properties that give bone its necessary high strength and fracture toughness, as well
as elasticity, which allows bone tissue to absorb shock [4]. These unparalleled characteristics are
highly centered on the role of the nano-size of the two main constituents, as well as their
positioning, which allows for the mineral phase to absorb the load while the protein matrix
transfers the load between HA minerals via shear (see Figure 2.8) [2, 88, 89]. For bone
regeneration applications, the mechanical properties of the scaffolds are also very important.
With load-bearing tissues, it is important for the scaffold to at least have sufficient mechanical
properties to withstand the stresses and loading in the in vivo environment. These mechanical
properties should be maintained for sufficient time for tissue to begin to in-grow and assume
some of the load [90]. The inclusion of HA nanoparticles within/on an artificial structure not
only enhances mechanical properties and mimics the natural microstructure of bone, but also
creates a bioactive material, which results in new tissue formation once incorporated inside the
body as a scaffold for bone regeneration [91]. This has to do with chemical reactions occurring
at the surface of the polymer in which dissolution products of the HA on the surface of the
construct, such as calcium and phosphate ions, upregulate gene expression that controls
osteogenesis and the production of growth factors. This leads to ECM production and the
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formation of carbonated hydroxyapatite, which allows the scaffold to create a bond with the
natural tissue around it [92, 93]. For these reasons, polymer/ceramic composites are increasingly
being looked at as an alternative to current tissue engineering approaches.

Figure 2.8: Schematic showing load carrying ability of collagen/HA composite structure [89]

There are many different ways to create a polymer/ceramic composite structure. Many
methods rely on a biomimetic approach, often utilizing techniques that involve the immersion of
polymer nanofibers into solutions that contain ion concentrations similar to that of human blood
plasma. There are many different ways to do this, including the use of SBF,[62-65] alternating
soaking in concentrated calcium and phosphate solutions, [66-70] and others [50, 94-96].
Oftentimes, with the first two methods, the surface of the polymer has to be functionalized with
anionic functional groups in order for the positively charged calcium ions to have a place to bind
to the surface of the polymer and initiate nucleation of hydroxyapatite. These methods imitate
what naturally occurs in the body when bone is forming. However, the most popular and easy
way to create a polymer/ceramic composite with electrospun nanofibers is to simply add HA
nanoparticles into the polymer solution prior to electrospinning [45, 51-61]. This method is
very straightforward and has been proven to improve the mechanical properties of the scaffold as
well as enhance cell attachment and proliferation [53, 54]. Electrospraying HA nanoparticles
onto the polymer nanofiber surface is also an effective technique, but not utilized quite as often
as the other methods [48].
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One of the most common ways to create a HA coating on polymer nanofibers is
immersing them in SBF, which has ion concentrations similar to that of human blood plasma
(Table 5) [97]. Though SBF immersion is often utilized as a method to determine scaffold
bioactivity, it is also used to create a biomimetic coating on scaffolds, which also renders the
scaffolds bioactive. The ease of fabrication, plus the low cost and effectiveness, makes this
method one of the most popular to create this biomimetic coating. Also, different concentrations
of SBF, such as 1.5X, 5X, and 10X, can be used to shorten the mineralization time. When a
material is immersed in SBF, the calcium ions present in the solution are attracted to anionic
functional groups on the polymer chain, such as hydroxyl and carboxyl groups, to name a few,
and chelation begins on the surface. The phosphate ions also begin to bind and this initiates the
formation of a HA coating on the surface. Depending on the conditions, both the composition
and structure of the mineral formed can be almost identical to that of natural bone mineral. This
method is very popular because it forms a biomimetic coating on the polymer’s surface, which
resembles the hydroxyapatite that forms on collagen’s surface in bones’ extracellular matrix.
This also creates an osteoconductive surface for implantation. Chen et al. [65] used this method
to create a continuous mineral layer on the surface of an electrospun scaffold. Prior to
immersion in SBF, however, the nanofibers were also subjected to a hydrolysis treatment in
order to increase the functional groups on the polymer surface. Results indicate an enhanced
ability for scaffolds to mineralize when a hydrolysis treatment was performed prior to SBF
immersion. However, no mechanical testing or cell studies were conducted. Yang et al. [62]
conducted a similar study, including a hydrolysis treatment, but used 10X SBF instead. The
optimal mineralization time was determined to be 2 hours, in which a homogenous mineral
coating was observed. Similarly, no mechanical testing or cell studies were conducted. Li et al.
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[63] also used SBF for bone tissue engineering applications, but did conduct cell studies on their
mineralized electrospun scaffolds. It was determined that preosteoblasts attached, spread, and
proliferated better on electrospun nanofibers mineralized by SBF as compared to non
mineralized nanofibers. Likewise, Ito et al. [64] used this mineralization method and compared
polymer nanofibers and films, and found that cells not only attached to the nanofibers
significantly better as compared to the films, but also attached onto the mineralized fibers just as
well as the unmineralized fibers.

Table 2.4: Ion concentration of different SBFs compared to human blood plasma [97, 98]

Immersing polymer nanofibers in alternating calcium and phosphate solutions is another
method in order to create a biomimetic HA coating on polymer nanofibers (Figure 2.9). This
method is very similar to SBF in respect to the mechanism which forms the biomimetic coating.
There has, however, been some data that proves that this alternating soaking method actually
works better than immersing in SBF. This is probably due to the introduction of larger amounts
of calcium and phosphate ions since the solutions are highly concentrated. In one particular
study by Yin et al. [67], though not on polymer nanofibers, functionalized and unfunctionalized
polymer scaffolds were immersed in either SBF or alternating CaCl2 and Na2HPO4 solutions.
Results indicated that SBF did not form apatite on the unfunctionalized polymer scaffold and
barely formed apatite on the functionalized polymer scaffold, whereas both scaffolds that were
immersed in alternating CaCl2 and Na2HPO4 solutions showed extensive apatite formation and
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growth. Utilizing this method, the calcium solutions typically consists of calcium chloride
(CaCl2) [66-69, 99-103], though others have been used. The phosphate solution typically used is
dihydrogen sodium phosphate (Na2HPO4) [66, 67, 69, 100-103], however, diammonium
phosphate ((NH4)2HPO4) [99] and monopotassium phosphate (KH2PO4) [68] are also used. This
method works by introducing a large amount of calcium ions to the anionic functional groups
present on the polymer chains, which initiates the nucleation and allows for mineral growth.
Taguchi et al. [70], demonstrated this method very well, though not on electrospun nanofibers.
This method was used to create a HA coating on Poly (vinyl alcohol) (PVA) gels. The polymer
samples were immersed in 200 mM CaCl2 for 2 hours and then soaked them in 120 mM
Na2HPO4 for 2 hours, as well. This cycle was repeated 5 times and x-ray diffraction (XRD) data
showed the sample peaks matched the 5 main peaks of HA. Similarly, Madhumathi et al. [103]
also used this same method on chitosan hydrogels and energy dispersive x-ray spectroscopy
(EDX), fourier transform infrared spectroscopy (FTIR), and XRD data suggests that the coating
produced was very similar to that of HA. Further, this scaffold showed excellent
biocompatibility as compared to the control. This same group, Madhumathi et al. [102] used this
method to create a biomimetic HA coating on β-chitin membranes, as well, and observed similar
EDX, FTIR, and XRD data, but also conducted in vitro cells studies and noticed significantly
better cell attachment and spreading on the composite membranes as compared to the controls.
However, this method is also very successful in forming a biomimetic HA coating on
electrospun nanofibers. Shalumon et al. [101] used this method to create a HA coating on
carboxymethyl chitin/poly(vinyl alcohol) electrospun nanofibers and EDX data demonstrated a
Ca/P ratio of 1.89, which is very similar to that the theoretical value of the Ca/P ratio of HA that
is found in natural bone, often described to be 1.67 [68, 104]. Ngiam et al.[66] used this same
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method and observed similar results. Alternate soaking in concentrate calcium and phosphate
solutions was used to create a hydroxyapatite coating on two different types of polymer
nanofibers, either poly(lactic-co-glycolic acid) (PLGA) or a PLGA/Collagen copolymer. They
determined that their coating had a Ca/P ratio of 1.67, which is equivalent to the theoretical value
of the Ca/P ratio of HA that is found in natural bone. Data also demonstrated that scaffolds
mineralized with this technique showed enhanced osteoblast attachment and spreading on the
PLGA scaffolds (Figure 2.10A), as well as enhanced protein secretion and ALP activity (Fig.
10C and 10D), though cell proliferation was significantly lower (Figure 2.10B). This decline
was attributed to the rough surface of the HA containing groups, which other groups have also
noticed [105-107]. This same group [69] conducted another study using different polymers and
observed the same results. An ALP assay was also conducted, but no significant difference
between the mineralized and unmineralized groups was seen. Another group, Yang et al. [68]
used CaCl2 and KH2PO4 solutions to create a HA coating on electrospun chitosan scaffolds. The
concentrations and amount of each solution was specifically chosen to exhibit a Ca/P ratio of
1.67/1. SEM, EDX, and FTIR data show a HA coating similar to that of natural HA. In vitro
data suggests ideal cell morphology and enhanced viability with these scaffolds.

Figure 2.9: Schematic of alternate soaking method
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Figure 2.10: Human fetal osteoblast (hFOB) attachment (A), proliferation (B), protein secretion
(C) and ALP activity (D) on various mineralized and unmineralized nanofiber scaffolds [66]
Another popular method to create electrospun ceramic/polymer composites is to blend
HA nanoparticles directly into the polymer solution prior to electrospinning (Figure 2.11). This
method is by far the easiest and is very cost effective. HA nanoparticles, ranging in composition
and size, can be incorporated into varying polymer solutions prior to electrospinning in order to
create a composite material. Many polymers, including polycaprolactone (PCL) [53, 56], poly
(D, L-lactide-co-glycolide (PLGA) [51, 52, 55, 58], poly (D,L-lactic acid) (PLA) [57], and polyL-lactid acid (PLLA) [45, 54] can be used. These HA nanoparticles are usually incorporated in a
two step method in order to ensure proper dispersion. This method is far simpler than immersion
in SBF or alternating calcium and phosphate solutions because it not only saves time, but ensures
that the proper composition of HA is used. With other methods, the composition of the coating
can never be guaranteed to be exactly similar to that of natural bone. Also, different
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concentrations of HA can be added, with different groups coming up with different optimal
concentrations of HA, in order to enhance mechanical properties, cell attachment, and ECM
production. For instance, Kim et al. [57] used this technique in order to produce composite
nanofibers. These nanofibers showed significantly higher cell attachment, after 6 hrs, and
proliferation, after two days. Significantly higher ALP activity was also observed with the
composite scaffolds as compared to pure polymer scaffolds and TCP after 7 days. Jose et al.
[51] also used this two step blending method to determine the optimal HA concentration. First
the polymer was dissolved in the solvent at the desired ratio. Then, the same solvent was used
and the desired amount of HA nanoparticles were dispersed into the solvent and sonicated for 90
minutes to break up any nanoparticle agglomerations. The two solutions were then combined at
the desired ratio and stirred for 90 minutes. Then, either 0.0, 0.2, 0.5, 1.0, or 5.0 wt%
HA/polymer solutions were created and used them to determine the optimal HA concentration.
It was concluded that 0.5 wt% HA allowed the best mechanical properties and showed an
excellent cellular response. When specifically comparing this concentration of HA to the
samples that contained no HA (0.0 wt%), the mechanical properties were significantly greater,
though no in vitro or in vivo studies were conducted comparing these groups. Similarly, Yang at
al. [53] utilized this same method, but actually synthesized their HA nanoparticles by a
precipitation reaction. The creation of HA nanoparticles was confirmed by XRD and FTIR. The
nanoparticles were then included in the polymer solution in the same two step process, as
previously described. Varying the amounts of HA inclusion was also studied, and it was
determined that there was a significant increase in mechanical properties and ALP activity of
osteoblast-like cells after 1, 4, and 8 days with an increase HA concentration. Prabhakaran et
al.[45] also used this method, but did not use a two step process. HA particles were directly
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incorporated into the polymer solution at a weight percent of 20% and then electrospun. When
measuring mechanical properties of these fibers compared to pure poly (lactic acid) (PLLA)
controls, this group noticed significantly lower tensile strength for the composite fibers (Figure
2.12A). The authors did not hypothesize why this occurred, but it may be due to HA
agglomerations in the nanofibers causing fiber breakage, and therefore lower mechanical
properties. However, for in vitro cell studies, when comparing these fibers to non-HA
containing controls, the proliferation rate (Figure 2.12B), ALP activity (Figure 2.12C), and
calcium deposition (Figure 2.12D) of human fetal osteoblasts was significantly higher at all
times points in the HA-containing group. Alizaren red staining also proved higher mineral
deposition for these scaffolds (Figure 2.12E). Sui et al. [54] created polymer/HA composite
scaffolds in a similar manner, and showed that the HA-containing nanofibers scaffolds had a
significantly higher specific surface area, due to the HA nanoparticles, and therefore greater
cumulative pore volume, and theorized that this would allow for better cell penetration and
growth of cells. It was later proved that these scaffolds actually did demonstrate enhanced
osteoblast attachment, viability and proliferation, as well as enhanced mechanical properties.
Nie at al. [55] used similar method to the above mentioned groups, and also compared different
HA concentrations. However, bone morphogenetic protein 2 (BMP-2) was also included in the
scaffolds for enhancing bone tissue formation. It was found that the scaffolds containing HA
showed significantly better cell attachment. Viability and proliferation was also observed to be
enhanced, but was likely affected by the inclusion of BMP-2. Lastly, Lee et al. [58] conducted a
similar study by seeding PLGA and PLGA/HA composite scaffolds with human mesenchymal
stem cells (hMSCs) and noticed there was a significantly higher expression of osteogenic
differentiation genes, such as ALP and osteocalcin (OCN), for the cells seeded onto the
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composite scaffolds. A significantly higher amount of calcium was also observed on these
scaffolds as compared to the control.

Polymer in solvent

Composite solution
I
O

HAp in solvent

Figure 2.11: Two step blending method used to create polymer/ceramic composite fibers
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Figure 2.12: Stress-strain curve of varying mineralized and unmineralized scaffolds (A). hFOB
proliferation (B), ALP activity (C), and calcium deposition (D) on varying scaffolds. Alizaren
red staining of PLLA scaffold (top left), PLLA/HA scaffold (top right), PLLA/Col/HA scaffold
(bottom left), TCP (bottom right) (E) [45]
Other methods, even though not as popular, have been shown to be very effective in
creating a biomimetic HA coating on polymer nanofibers. For example, electrospraying,
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demonstrated by Gupta et al. [48], utilizes a charged jet of HA nanoparticles simultaneously with
electrospinning in order to produce a similar composite scaffold as when HA is blended into the
polymer solution. The difference between the two methods, however, might be what makes it
better, suggests Gupta et al. Electrospraying allows for the HA to remain on the surface of the
nanofibers, whereas the blended method embeds the HA nanoparticles within (Figure 2.13).
This makes a huge difference seeing as the bioactivity and osteoconductivity of the scaffold
relies on this property. For this reason, Gupta et al. set out to prove that this method creates a
composite scaffold that is better for bone regeneration applications. This group compared
polymer scaffolds (control) with polymer/ceramic composites created by either the blending
method or electrospraying method. Results indicate similar mechanical properties and
proliferation rates for both composite scaffolds (though significantly higher than the controls).
However, when seeded with osteoblasts, there was significantly higher ALP activity and
mineralization deposition on the electrosprayed scaffolds as compared to the blended composite
scaffolds. This indicates that this method might create a more bioactive and osteoconductive
scaffold than blending HA nanoparticles into the polymer solution.
Another method used to create polymer/ceramic composites by electrospinning includes a
co-precipitation method [49, 50], which works in a very similar manner as the blending method,
however, both the organic and inorganic components are precipitated together prior to dissolving
and electrospinning. In short, Song et al. [49, 50] dissolved Ca(OH)2 in cold distilled water and
separately dissolved the polymer (collagen, in this case) in H3PO4. Both solutions were then
added to a reaction vessel containing a TRIS/HCl buffer solution, and contained at a pH of 9.
The amounts of Ca and P were predetermined to get the desired composition. The mixture was
stirred vigorously for 48 hrs followed by washing and lyophilization. This dried polymer/HA

35

composite can then be dissolved in an organic solvent and electrospun. Song et al. [50] found
that by using scaffolds created by this method, as compared to pure polymer controls, cell
proliferation was significantly greater after 2 days. Also, though at day 7 a decrease in ALP
activity was seen, by day 14 a significant increase in ALP activity was seen in the composite
scaffolds. Zhang et al. [96] used a very similar method, but used Chitosan as their polymer.
Similar results were found indicating a significant difference in cell proliferation and mineral
deposition at days 10 and 15 of the composite scaffold as compared to pure polymer scaffolds.
The last method discussed, which is used to form polymer/ceramic composites by
electrospinning, is extremely different than the methods previously described, but worth
mentioning. Zuo et al. [95] used a method to create a composite scaffold that is actually the
reverse of what most people are doing. Instead of mineralizing the nanofibers, Zuo et al. actually
incorporated electrospun polymer nanofibers into a ceramic bone cement in order to form a
composite scaffold. It was found that by incorporating electrospun nanofibers into the cement,
the scaffold became less brittle and actually behaved similar to that of a ductile material due to
the fibers. Composite scaffolds with different polymers and fiber diameters were then tested in
order to determine which scaffold demonstrated the most ideal mechanical properties. However,
no cell studies were conducted and this method would most likely be used for a bone substitute
instead of bone regeneration applications.
The methods discussed above that are used to create polymer/ceramic composites are all
successful ways to create not only biomimetic scaffolds, but scaffolds that are bioactive and
osteoconductive, as well. All of the methods have their downfalls, but the methods that create a
HA coating most similar to that of natural bone in both structure and composition typically are
the most effective. Mechanical testing data indicates significantly higher mechanical properties,
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which is very important in load-bearing tissue engineering applications. Also, cells studies show
promising results, demonstrating enhanced cell attachment, proliferation, and ALP activity.
However, many researchers have not attempted to combine this biomimetic method with others
in order to more effectively regenerate bone.

Figure 2.13: Incorporation of HA nanoparticles by blending (a) and electrospraying (b) [48]

2.5.4 Biomolecule/Drug Encapsulation/Delivery
When bone tissue is injured, the body goes through a natural process in order to repair
this tissue to its normal strength, structure, and function [108]. Immediately after a fracture,
growth factors and cytokines can be instantly detected at the fracture cite, which are secreted in
order to recruit other cells to begin the repair process. These growth factors can include
fibroblast growth factor (FGF-1 and -2), platelet-derived growth factor (PDGF-AA, -AB, -BB),
transforming growth factor-β (TGF-β1 and –β2), and bone morphogenetic protein (BMP-2, -3, 4, and -7) [108]. However, not all fractures can be repaired by this natural process. Some
fractures result in a nonunion and surgical intervention must take place. However, for tissue
engineering applications, these natural proteins that are normally expressed in the body can be
utilized to help the bone regeneration process. Using electrospun scaffolds, these same
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biomolecules can be incorporated into the scaffolds in order to enhance bone regeneration when
the body can’t heal the defect itself.
The growth factors mentioned above are the ones expressed immediately after injury at
the fracture site and are the ones most often incorporated into scaffolds for bone regeneration
applications. Biomolecules can be incorporated into nanofibers-based scaffolds by many means,
including adsorption of the biomolecule onto the surface, encapsulating the biomolecule into the
polymer solution prior to electrospinning, and the creation of biomolecule/polymer nanoparticles
that can be encapsulated into the polymer solution prior to electrospinning [59]. Nie et al. [59]
created biomimetic electrospun scaffolds by including both HA nanoparticles as well as BMP-2.
All of the methods of biomolecule incorporation were then compared in order to determine
which was most effective (see Figure 2.14 for schematic). It was discovered that all methods
released BMP-2, and the BMP-2 retained its bioactivity. However, it was determined that the
scaffolds created by encapsulating BMP-2/polymer nanoparticles within electrospun nanofibers
showed a much better and more linear release curve as compared to the other groups, which
showed a great initial burst release (Figure 2.15A). These curves also corresponded to
cytotoxicity data, where cells seeded onto scaffolds that showed an initial burst release showed
significantly lower viability due to this burse release (Figure 2.15B). Further, the BMP2/polymer nanoparticle encapsulated fibers also demonstrated enhanced cell attachment (Figure
2.15C). However, these samples were not compared to a control not containing BMP-2. Li et al.
[60] conducted a study based on the encapsulation of BMP-2 in silk/PEO electrospun nanofibers
that also contained HA nanoparticles. It was also determined that the encapsulation of both HA
and BMP-2 enhanced calcium deposition after 31 days in culture and BMP-2 transcript levels
after 14 days in culture. However, no significant difference was seen in bone sialoprotein (BSP)
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or collagen I production and no other cell studies were performed. Fu et al. [61] also compared
two of the methods for BMP-2 inclusion. The effects of adding different concentrations of HA
nanoparticles were studied when BMP-2 was encapsulated within the fiber (F1-F3), as well as
compared those to a scaffold that encapsulated HA nanoparticles, but loaded BMP-2 after
scaffold fabrication (F4). Mechanical testing determined that the inclusion of a proper amount of
HA nanoparticles increased the tensile stress of the scaffolds. Release curves indicate a burst
release for F4, which is to be expected since it can diffuse into the media without the fibers
having to degrade. The other release profiles (F1-F3) were very similar, even though it is
important to note that the samples not containing any HA nanoparticles released the BMP-2 the
slowest. These results correlated with the results for ALP activity of the seeded scaffolds, with
F4 showing significantly higher ALP activity than the others in the first couple weeks (due to the
burst) then significantly lower in the last couple of weeks. In vivo studies indicate that the
scaffolds that containing both BMP-2 and HA are required to retain the bioactivity of BMP-2
and to have any effect on bone formation, yet it was not determined which method of BMP-2
incorporation and what concentration of HA was best for bone regeneration applications.
Schofer et al. [109] also incorporated BMP-2 into their electrospun scaffolds for bone
regeneration applications. BMP-2 was incorporated by blending it into their polymer solution
prior to electrospinning. When seeded with hMSCs, results indicate an increase in expression of
genes associated with an osteoblast lineage, as compared to control that did not contain BMP-2.
Though BMP-2 and other growth factors are very popular to use for this application,
other biomolecules can also be incorporated into polymer nanofibers, including genes and
pharmaceuticals. For instance, Pişkin et al. [110] incorporated simvastatin, a statin drug known
to stimulate bone regeneration, into electrospun PCL nanofibrous scaffolds. The drug was
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incorporated with two different ways: by either blending it with the polymer solution prior to
electrospinning or by loading it after electrospinning. The scaffolds were then spiral wound into
a 3D structure and implanted them into a critical size cranial defect in rats. Histological data and
MicroCT results from the in vivo study indicate that the PCL scaffolds in which the simvastatin
was incorporated prior to electrospinning showed significantly better ossification and
mineralization of the defect area.

Figure 2.14: Methods for incorporating biomolecules into/on polymer nanofibers [59]
The methods discussed above for biomolecule inclusion in electrospun nanofibers have
all been shown to be effective in maintaining the bioactivity of the biomolecule, as well as
enhancing ALP activity and other genes associated with bone regeneration. In general,
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encapsulating biomolecules into the polymer solution prior to electrospinning, either alone or in
nanoparticles, has been proven to be more effective than adsorbing onto the surface, due to the
lack of a burst release provided by the previous method. This method has sufficient
encapsulation efficiency and has been shown to release the biomolecule steadily over a period of
60 days in vitro. Sustained controlled release of biomolecules is very important for bone
regeneration application since it is a slow process. Some groups have also combined this method
with other biomimetic techniques, such as composite scaffolds and 3D scaffolds, and have seen
very promising results. By doing this, and creating a 3D bone-like structure using electrospun
nanofibrous scaffolds, more advances in bone tissue regeneration will likely take place.
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Figure 2.15: DNA release over 60 days corresponding to groups in Figure 2.14 (the numbers in
each groups correspond to the amount of HA inclusion - 0%, 5%, and 10%) (A), cytotoxicity of
each scaffold (corresponding to the groups in Figure 2.14) (B), and cell attachment on each
scaffold [59]

2.5.5 Creating 3D Electrospun Nanofiber-based Biomimetic Scaffolds
Using electrospun nanofibrous scaffolds, it is also possible to create a 3D bone-like
structure. This type of structure can be created numerous ways, including stacking, rolling, or
actually electrospinning a 3D structure. When combined with other biomimetic methods, such
as growth factor delivery or aligned nanofibrous scaffolds, this method has been proven to be
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successful in inducing bone tissue formation in vivo [110]. The most common way to create a
3D bone-like structure is to stack seeded electrospun scaffolds on top of each other in a layer-bylayer approach. However, rolling scaffolds into cylinders is also popular, as well as actually
electrospinning 3D structures. For instance, Pişkin et al. [110], as mentioned above, created a
3D structure by rolling electrospun simvastatin-loaded PCL scaffolds into spirals. This
biomimetic technique demonstrated enhanced bone formation and mineralization in vivo as
compared to the control, in which the defect did not contain a scaffold. Ekaputra et al. [111]
used a similar rolling technique, but formed a more tubular structure. 2 cm x 2 cm
PCL/Collagen scaffolds were seeded on both sides with pig bone marrow mesenchymal cells
(pBMMCs) then rolled them into cylindrical sHAes with a diameter of 6 mm. The scaffolds were
then wrapped in osteogenic cells sheets. When seeded with pBMMCs, these scaffolds
demonstrated enhanced bone tissue formation, with higher production of calcium, osteocalcin,
osteopontin, and collagen I.
Li et al. [85, 86] used a different approach and stacked their aligned electrospun scaffolds
in a layer-by-layer approach. This method is one that is most often utilized in order to create 3D
structures by electrospinning. This group introduced this method, and mentioned certain
applications, such as controlling hierarchical structures for bone regeneration, but conducted no
in vitro or in vivo studies with the scaffolds. Srouji et al. [112] also used a similar stacking
method, however, did not use aligned fibers, and therefore could not create patterned structures.
Thirty electrospun scaffolds were seeded with cells and stacked them on top of each other.
When compared to a TCP control, cell viability was comparable and not significantly different
for the 3D scaffold. Further, in vivo results indicate that the scaffolds support cell infiltration and
neovascularization. McCullen et al. [113] also utilized this stacking method to create a 3D
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bone-like structure, but altered the technique slightly. First, the scaffolds were created by
electrospinning, but then were laser ablated in order to create large pores in the scaffold. Cells
were then seeded onto the scaffolds and the scaffolds were bonded in layers by polymerizing
type I collagen to create thick 3D scaffolds. Results of in vitro cell studies after 21 days
demonstrate significantly higher cell proliferation and significantly higher mineral production on
the ablated scaffolds as compared to the unablated controls. This most likely has to do with
cellular infiltration into the scaffold due to the ablated pores. However, no in vivo studies were
conducted. Inanç et al. [114] also used the stacking method to create 3D bone-like structures.
First, PLGA nanofibrous scaffolds were created via electrospinning. These scaffolds were then
seeded with human periodontal ligament (hPDL) cells. Additional layers were added to the
scaffolds on days 3, 6, 9 and 12. No significant difference was seen in cell viability as
compared to TCP controls. hPDL cells were observed to attach and spread very well on the 3D
structure. Further, the cells showed significantly higher production of osteopontin and bone
sialoprotein after 21 days in culture.
Others have actually electrospun 3D nanofibrous scaffolds, using a “wet-spinning”
technique. This is most often done by collecting the nanofibers in a metal collecting bath that
allows for a 3D “sponge-like” structure. For instance, and Ki et al. [115] and Shin et al. [116]
have used this method and collected 3D nanofibrous scaffolds in a metal collecting bath
containing methanol. The first group, Ki et al. [115], also created 2D electrospun scaffolds in
order to compare the two types. Physically, the 3D scaffold was 1.5 mm thick whereas the 2D
scaffold was 0.15 mm thick, however, the pore size and porosity was also higher in the 3D
scaffolds. This group performed cell studies which showed significantly higher proliferation of
cells on the 3D scaffolds when compared to both 2D scaffolds and TCP after 5 and 7 days of
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culture (Figure 2.16). The authors suggest that this is most likely due to the ability for cells to
attach and migrate better on theses scaffolds due to its structure and high porosity. Later, Shin et
al. [116] used the same method to create 3D scaffolds (Fig. 17A) but used a different material
and also measured proliferation and ALP activity as well. When compared to TCP, these 3D
scaffolds showed significantly higher proliferation after 4 and 7 days of culture (Figure 2.17B)
as well as significantly higher ALP activity after 28 days (Figure 2.17C).
Others have combined electrospun scaffolds with scaffolds created by other techniques to
create a 3D bone-like scaffold for bone regeneration. For instance, Martins et al. [117] combined
both electrospinning and rapid prototyping in order to create a 3D bone-like structure. This
method is very similar to the layer-by-layer approach discussed above, but incorporated the
layers of electrospun nanofiber scaffolds within the microfiber meshes created by rapid
prototyping. The scaffolds created by rapid prototyping alone were then compared to the
scaffolds with incorporated electrospun nanofibers and it was found that after 7 days in culture,
the scaffolds that incorporated electrospun nanofibers showed significantly higher proliferation
and ALP activity.
3D bone-like structures are the ultimate biomimetic technique that can eventually lead to
bone regeneration. The techniques listed above have been proven to form new bone tissue, in
vivo. However, current strategies are not utilizing all of these biomimetic techniques to create
the ultimate 3D bone-like structure. Lacking certain qualities, such as nanofibers alignment and
a composite structure, which enhance bone cell response and mechanical properties, don’t allow
for a 3D “bone-like” structure. By combining all of the biomimetic techniques discussed in this
review into one 3D structure, the scaffold would more closely mimic the structure and
composition of bone, and it would be more feasible to regenerate bone tissue.

45

Figure 2.16: Preosteoblast proliferation on TCP, 2D, and 3D nanofibrous fibroin scaffold [115]
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Figure 2.17: 3D nanofibrous structure produced by wet-spinning method (A), preosteoblast
proliferation on TCP and 3D scaffold (B), and ALP activity of preosteoblasts on TCP and 3D
scaffolds [116]

2.6 Scaffold Fabrication Techniques for Cancellous Bone Tissue Engineering
There are many tissue engineering techniques currently being investigated as scaffold
fabrication methods for cancellous bone tissue regeneration. Though many of these studies don’t
necessarily specify the type of bone to be regenerated, they often involve a highly porous
scaffold that mimics cancellous bone (Figure 2.18), thus producing newly regenerated tissue
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with a similar structure. There are many different methods utilized to create highly porous
scaffolds, including solvent casting/particulate leaching [118-123], phase separation [124-126],
fiber bonding [127], freeze drying [128-130], gas foaming [131, 132], porogen leaching [133,
134], and rapid prototyping methods [135-138]. These methods can be used to produce
scaffolds with varying compositions and structural organizations.
Some advantages and disadvantages of various fabrication methods can be seen in Table 2.5.
Other exceptional attributes, beyond porosity, include ease of fabrication, osteoconductivity,
bioactivity, high surface area, and excellent mechanical properties [139-141]. Scaffolds can be
created exceeding 90% in porosity, with extensive interconnectedness, encouraging cell
infiltration and new tissue ingrowth [141]. However, these types of scaffolds still possess some
downfalls, including minimal degradability, in some instances, and lower mechanical properties
when the porosity is high. Further, oftentimes a disorganized bone tissue is formed when
utilizing these types of scaffolds leading to increased healing time.
Many different types of materials can be used to produce highly porous scaffolds for
cancellous bone tissue regeneration. These materials can include polymers, ceramics or
combinations thereof. Many time researches will create a composite structure utilizing both
ceramics and polymers in order to take advantage of the advantageous properties of each
material type. Ceramics are very popular due to their similarities to the composition of native
bone. Different types of ceramics are often utilized, most often being either hydroxyapatite (HA)
[133, 142-145] or β-tricalcium phosphate (βTCP) [142, 146-148], due to similar composition to
biological hydroxyapatite and additional excellent properties. Bioactive glass scaffolds are also
very popular due to many excellent properties, including osteoconductivity [145, 149-153].
However, the use of polymers is becoming increasingly popular for this application due to many
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excellent properties, such as biocompatibility and tunable degradation rates. Some polymers
being used for this application include collagen [154, 155], chitosan [144, 156-158],
polycaprolactone (PCL) [155, 159, 160], and poly (lactic-co-glycolic acid) (PLGA) [148, 158,
161], to name a few. Most of these polymer scaffolds, however, incorporate a ceramic
component for added osteoconductivity and mechanical properties.
These types of highly porous scaffolds have been studied extensively, both in vitro and in
vivo, for bone regenerative capabilities. Beyond the porosity, the osteoconductive and bioactive
nature of the ceramic components along with the biodegradability and durability of polymer
components allows for significant bone ingrowth and regeneration.

Figure 2.18: Typical highly porous ceramic construct for bone tissue engineering [133]
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Table 2.5: Pros and cons of different fabrication methods for polymer/ceramic composites [162]

2.7 Other Tissue Engineering Approaches for Bone Tissue Regeneration
Though much emphasis has been placed on creating 3D biomimetic scaffolds for bone
tissue regeneration, it is necessary to mention other tissue engineering methods investigated in
this field, that have shown great promise. While biomimetic electrospun techniques and highly
porous scaffolds, as discussed above, are included in this new generation of biomaterials, others
include, but are not limited to, hydrogels [163-169], 3D foams [170-174], and microsphere-based
scaffolds [175-179]. These methods, as compared to conventional scaffolds, have shown
increasing interest due to their unique ability to be able to be injected into the defect site noninvasively, as well as by possessing many other excellent properties. Of these methods,
hydrogels are of great interest, due to their many excellent qualities for this application,
including the ease of loading growth factors and drugs, as well as possessing tunable degradation
rates. Patterson et al. [163] created a hyaluronic acid (HA) hydrogel containing either BMP-2
and/or vascular endothelial growth factor (VEGF) with differing degradation rates in order to
determine how this affected the collagen orientation of new bone formed under these conditions.
They determined that the co-delivery of both of these growth factors from the HA hydrogels
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stimulated new bone formation and mineralization, but also showed that the collagen fibers
orientation could be guided depending on the degradation rate. Others have combined the
excellent properties of a hydrogel with ceramic beads in order to created an injectable composite
structure for this application [180, 181]. Zhao et al. [182] expanded on this approach, however,
and created an injectable calcium phosphate-alginate hydrogel-paste seeded with umbilical cord
mesenchymal stem cells. This paste would have all the great properties of a hydrogel, such as
injectability, and the ability to load growth factors and seed cells, but also greatly improves upon
the mechanical properties. Results have indicated mechanical properties similar to reported
values of cancellous bone. Similar to hydrogels, 3D foams are also a popular method for bone
regeneration applications, though they are most often employed for trabecular bone regeneration
[170, 172]. There are a few methods utilized to create foams for this application, one of the most
popular being a polymer foam replication technique, in which a polymer foam is either
electrosprayed or immersed into a HA/bioactive glass particle slurry in order to fully coat the
foam and create a trabecular bone-like architecture. However, other methods are also utilized,
including creating composite foam solutions that are injectable and form once inside the body
[171]. Results of Fu et al. [170] have indicated mechanical properties similar to that of natural
trabecular bone, and Montufar et al. [171] demonstrated excellent cell viability, proliferation, and
differentiation on these foams. One last method that needs to be discussed that has shown much
promise is microsphere-based scaffolds for bone regeneration [175-178]. These microspheres
can be used in conjunction with many other techniques, such as injectable
hydrogels/pastes/solutions and are a great way to incorporate growth factors and control their
release. They are also often employed in order to take advantage of the properties of two
different materials, such as polymers and ceramics, in order to enhance bone formation. Very
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promising in vitro data, such as enhanced proliferation, ALP activity, and calcium secretion, as
well as in vivo data, such as new bone tissue formation, has been shown using microspheres for
bone regeneration [175-178].
Though not entirely similar, it is important to note that many of these methods are also
attempting to emulate the natural structure of bone, by creating 3D biomimetic structures,
including polymer/ceramic composites and growth factor inclusion. While these methods have
shown promise for bone regeneration applications, nanofibers-based methods seem to be the
most promising in order to regenerate cortical bone. These other methods have shown great
potential in forming trabecular bone in vivo, yet more structured and mechanically stable bone is
required for cortical bone regeneration. The highly aligned structure of electrospun nanofibers
direct cell alignment and can guide new tissue growth to form a structure more similar to that of
natural cortical bone.

2.8 Conclusions, Current Challenges, and Future Directions
In all, biomimetic scaffolds with structural, compositional, and mechanical properties
similar to those of natural bone hold great promise for bone tissue engineering. Mineralized
electrospun nanofiber array-based biomimetic scaffolds are ideal substrates to support osteoblast
or osteogenic stem/progenitor cell attachment, alignment, proliferation, and differentiation, and
offer osteoinductivity and osteoconductivity to promote bone tissue formation. Further
incorporation controlled delivery schemes of biomolecule/growth factors would fine-tune cell
response for bone tissue regeneration.
Current challenges facing bone tissue regeneration lie in the fact that there is an
additional requirement for these scaffolds as opposed to other tissue engineering scaffolds, and
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that is sufficient mechanical properties. To date, there isn’t much evidence of a material for
bone tissue engineering scaffolds that can promote osteoconductivity and osteoinductivity in
order to allow for new bone in-growth, but also support the necessary in vivo loads that are
characteristic of this tissue. Further, scaffolds that have been able to promote new tissue
formation have not been able to successfully create bone that is “functional and mechanically
competent” [183].

Oftentimes the bone tissue created is highly disorganized and the acquired

tissue architecture is not like that of natural bone [184]. Another great challenge facing this
field, as well as all tissue engineering fields, is the ability to vascularize the new tissue. For
tissues greater than 100 to 200 μm in thickness, there must be a blood vessel supply to deliver
oxygen and nutrients to the tissue and to remove waste in order for the tissue to survive. Current
strategies in this field have not been able to create functional blood vessels for this purpose.
Other challenges relating to all tissue engineering fields, such as achieving proper degradation
rates, are also evident in the field of bone tissue engineering.
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CHAPTER 3
MINERALIZED NANOFIRIL ARRAYS AS BUILDING UNITS FOR CORTICAL BONE
TISSUE ENGINEERING
3.1 Introduction
Bone is composed of both organic and inorganic components, with the inorganic hydroxyapatite
(HA), Ca10(PO4)6(OH)2, forming between and elongating on the organic collagen fibrils. This structure
allows for enhanced mechanical properties that give bone its necessary high strength and fracture
toughness, which maintains its load-bearing function, as well as elasticity, which allows it to absorb
shock [1]. Currently, autografts and allografts are the main treatment methods for critical-size defects in
bone. However, issues associated with these methods, including donor site morbidity [2, 3] and donor to
recipient infection [4], have led researchers to steer more towards a tissue engineering approach. The
field of bone tissue engineering focuses on mimicking the structural and mechanical properties of
natural bone by creating a scaffold that closely resembles its structure. This scaffold would be placed in
the bone defect and would be a temporary biodegradable substitute for bone forming cells to attach to
and secrete new bone tissue.
An important task of tissue engineering is to achieve the morphology and mechanical properties
of the natural tissue using scaffolds that closely mimic the natural architecture and mechanical properties
of individual structural components in the tissue. To this end, many fabrication techniques have been
utilized to produce bone-like scaffolds, including solvent casting/particulate leaching [5-8], phase
separation [9-11], fiber bonding [12], freeze drying [13-15], gas foaming [16, 17], and rapid prototyping
methods [18-21]. Among them, electrospinning shows great promise [22-24], due to its unique ability to
create nanofibers that can mimic the collagen in bones’ extracellular matrix. Using this method,
nanofibers can be created with diameters that range from several nanometers to a few microns.
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Additionally, our lab has developed an apparatus that can create highly-aligned loose nanofibril arrays,
which further mimic the collagen microstructure in bone tissue [25]. This method allows for the use of
many different polymers, including either natural or synthetic polymers, or a combination of both.
To further mimic the structure of native bone, HA crystals can also be incorporated onto the
nanofibril arrays, with many methods mimicking the actual natural process of bone mineralization.
Though methods exist in which HA nanoparticles are simply added into the polymer solution prior to
electrospinning [26, 27], or HA is directly electrosprayed onto the surface [28, 29], biomimetic methods
are becoming increasingly popular [30, 31]. These methods are simple, cost effective, and, most
importantly, form a mineral coating that more closely mimics the microstructure of the extracellular
matrix of bone. There are many different ways to achieve this biomimetic coating, with the most
popular method being the use of simulated body fluid (SBF). SBF is a salt solution that contains ion
concentrations similar to that of human blood plasma. When incubating polymer scaffolds in this
solution, calcium ions are attracted to anionic functional groups present on the polymer chains. This
begins the nucleation of hydroxyapatite on the nanofibrils surface [32]. For surfaces that do not contain
anionic functional groups, an easy surface functionalization method can be conducted, such as surface
hydrolysis, to form these charged groups. By creating this HA coating, not only may surface and
mechanical properties more closely mimic those of natural bone, but the osteoconductivity and
bioactivity of the scaffolds may also be improved.
In the present study, biomineralized polymer nanofibril array scaffolds were created as the
fundamental building unit for bone regeneration. PCL was chosen as a model polymer for nanofibril
array fabrication because it is biocompatible, non-toxic, and can be degraded under physiological
conditions by hydrolysis [33]. Further, PCL has a degradation rate that is slower than most polymers,
and therefore will coincide better with bone regeneration. Though PCL has many excellent properties
for bone regeneration applications, the mechanical properties of most polymers, including PCL, are not
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suitable. For this reason, many groups are focusing on creating polymer/ceramic composite materials.
This can be done by incorporating hydroxyapatite in/on polymer scaffolds in order to significantly
improve the mechanical properties, as well as more closely mimic the microstructure of bone. In this
study, a 5X SBF was employed to achieve this coating due to its ability to create synthetic HA coatings
more similar to that of natural HA found in bone, in a quick and efficient manner. By combining the use
of our electrospinning apparatus, which creates highly aligned loose electrospun fibrils, along with SBF
immersion, which provides biomimetic ceramic coating on the fibrils, we were able to create a scaffold
that mimics the composition and microstructure of the extracellular matrix of bone. This optimized
scaffold proved to possess significantly enhanced mechanical properties, as well as improved
osteoconductivity and bioactivity. In addition, preliminary cell studies indicate that, once seeded with
bone-forming progenitor cells, our scaffolds demonstrated excellent cell attachment, alignment,
proliferation and alkaline phosphatase (ALP) activity.

3.2 Materials and Methods
3.2.1 Materials
Polycaprolactone (PCL) (MW 70,000-90,00), sodium chloride (NaCl), sodium bicarbonate (NaHCO3),
sodium sulfate (Na2SO4), potassium phosphate dibasic trihydrate (K2HPO4·3H20 ), magnesium chloride
hexahydrate (MgCl2·6H20 ) and calcium chloride (CaCl2) were obtained from Sigma Aldrich (St. Louis,
MO). Extra dry N, N-dimethylformamide (DMF) was obtained from Alfa Aesar (Ward Hill, MA).
Dichloromethane (DCM) was obtained from Honeywell Burdick and Jackson (Muskegon, MI). Tris
((HOCH2)3CNH2) and sodium hydroxide (NaOH) was obtained from Mallinckrodt Baker (Phillipsburg,
NJ). Potassium chloride (KCl) was obtained from Fisher Scientific (Chicago, IL). Hydrochloric acid
(HCl) was obtained from EMD Chemicals, Inc (Gibbstown, NJ).
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3.2.2 Fabrication of nanofibrous scaffolds
A 17% (w/v) PCL solution was prepared by dissolving the polymer in a 3:1 ratio of DCM:DMF and
mixed for 2 hrs. The concentration and solvents were predetermined (data not published), though other
polymers and solvents can be used. Polymer nanofibrous scaffolds were fabricated by an electrospinning
method and were collected using a computer-controlled mobile track collection device developed in our
lab (Figure 3.1) [25]. The parallel rotating collection tracks allow for the creation of highly aligned
loose nanofibrous scaffolds with tunable scaffold thickness and fibril density. The PCL solution was
loaded into a 5 mL syringe and extruded out of a 23G blunt needle (Small Parts, Inc). The needle was
10 cm from the collection tracks and the flow rate was set at 0.025 mL/min using a Medfusion syringe
pump. The needle was connected to a high voltage power supply (Gamma High Voltage Research), in
which the applied voltage was set to 9 kV. The nanofibrils were collected on a collecting rack located at
the bottom of the rotating tracks for 7 minutes in order to achieve the desired fibril density. These
parameters were optimized for the device and specific polymer in previous studies (data not published).

Figure 3.1: Schematic of a modified parallel plate electrospinning device with mobile tracks [26].
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3.2.3 Surface hydrolysis
Surface hydrolysis was performed on the PCL nanofibrils by immersing them in a 0.1 M NaOH
solution, based on previous literature reports [34, 35]. The hydroxyl group present in NaOH hydrolyzed
the PCL to form hydroxycaproic acid [36]. The anionic hydroxyl and carboxyl groups formed on the
surface attract calcium ions in order to form a HA coating on the surface. This treatment was conducted
for either 15, 30, or 45 minutes in order to determine the proper hydrolysis time for optimal
mineralization of the scaffolds. An ESCALAB 250 X-ray photoelectron spectrometer (XPS) (Thermo
Scientific) was then used in order to determine the amount of –OH and –COOH groups present on the
surface of the groups hydrolyzed for either 15, 30, or 45 minutes.

3.2.4 Biomineralization of polymer scaffolds
5X SBF, which has 5X the ion concentrations of human blood plasma, was prepared by Kokubo’s
procedure as previously described [37]. The hydrolyzed polymer nanofibril scaffolds were immersed in
50 mL of 5X SBF solution and allowed to incubate under physiological conditions for either 12, 24, or
36 hours. After the specified time period, the samples were rinsed with DI water 4 times, dried, and
characterized. These parameters were determined by reading current relative literature and utilizing
concentrations and times which have previously been reported to be successful [38-40].

3.2.5 Surface characterization
A S4800 SEM (Hitachi) was used to evaluate the morphology and topography of the coated and
uncoated nanofibril arrays at an accelerating voltage of 10kV. Diameters of the coated and uncoated
electrospun nanofibrils, as well as fibril alignment, were determined from analysis of the SEM images
using image analysis software (ImagePro). After the mineralization process, SEM was also used to
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evaluate the coating on the fibrils at each time point in order to determine the parameters that created an
optimal HA coating.

3.2.6 Elemental composition determination
An INCA Energy 200 energy dispersive X-ray spectrometer (EDS) (Oxford Instruments) was used to
measure the elemental composition of the coating on the mineralized fibrils. The calcium and phosphate
content of the coating was specifically observed in order to determine the composition of the coating on
the fibrils. The calcium to phosphate (Ca/P) ratio was determined by comparing the weight percent of
calcium in the sample to that of the weight percent of phosphorus. This number was then compared to
that of the theoretical value of the Ca/P ratio of natural hydroxyapatite found in bone in order to
determine the similarity of their compositions. Element mapping was also conducted in order to
determine the location and extent of the coating. Finally, an X’Pert Pro MPD series X-ray diffractometer
(XRD) (PANalytical) was used to further confirm the composition of the coating, using monochromatic
Cu kα radiation in the 2θ 5-40° range.

3.2.7 Mechanical testing
The tensile mechanical properties of the mineralized and unmineralized scaffolds were analyzed using
an EZ Graph tensile tester (Shimadzu Corporation). Briefly, scaffolds were electrospun onto the
collecting rack and then glued onto a paper rectangle frame with inner dimensions of 9mm x 9mm. Half
of the nanofibrous scaffolds were mineralized in SBF before gluing onto rectangle frame. All scaffolds
were electrospun at the same time, and therefore the density of the fibers was the same. The frame was
then cut out and the short end of the rectangular frame was then placed into the grips of the tensile tester
and the sides of the frame were cut, allowing for only the fibrils to be affected by the deformation. Four
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scaffolds were tested for each group. The scaffolds were constantly strained at a deforming speed of 2.5
mm/min until mechanical failure, based on previous trials (data not published). The force/displacement
data was analyzed and used to calculate stress (MPa) and strain (%) values. The estimated crosssectional area was determined by using the length, and number of fibers/mm, and average diameter of
the fibers (last two different for mineralized and unmineralized). The stress/strain curves were then used
to determine the modulus, ultimate strength, ultimate strain, and toughness, which can be seen in table 2.
The elastic modulus was determined by measuring the slope at the beginning of the stress-strain curve,
the ultimate strength was determined by measuring the stress at failure, the ultimate strain was
determined by measuring the strain at failure, and the toughness was determined by taking the area
under the curve.

3.2.8 Human embryonic palatal mesenchymal (HEPM) cell culture on scaffolds
HEPM cells were obtained from ATCC and cultured until the 4th passage (P4). These cells were chosen
for this study as they are an established cell line and are known to differentiation into osteoblasts. The
cells were cultured in the complete medium of Alpha Minimum Essential Medium (αMEM),
supplemented with 10% fetal bovine serum (FBS), 1mM sodium pyruvate, 2mM L-glutamine, and 1%
penicillin/streptomycin. The culture was maintained in an incubator at 37ºC with 5% CO2.

Cells were seeded onto the scaffolds at a density of 1 x 104 cells/ml. An in vitro morphological study of
cultured HEPM cells seeded on mineralized and unmineralized scaffolds was conducted at day 5 of cell
culture. Briefly, the cells were fixed in 4% paraformaldehyde and stained with 4',6-diamidino-2phenylindole (DAPI; nucleus-blue) and Phalloidin 488 (actin-green). Confocal microscopy was used to
visualize the cells on the nanofibrils in order to assess the morphology, alignment, and attachment of the
cells. Four samples for each group were visualized, along with multiple locations on each sample.
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An Alamar Blue assay was conducted in order to assess cell proliferation. Briefly, HEPM cells were
cultured for 1, 3, 7, 10, and 14 days on mineralized and unmineralized scaffolds at a density of 1 x 104
cell/ml. At the specified time points, the cells were incubated in a 10% Alamar Blue solution for 4 hrs.
After 4 hrs, the solution was aspirated and analyzed at 570 and 600 nm using a SPECTRAmax Plus
plate reader (Molecular Devices Corporation). Four samples for each group were assessed and the
samples were each analyzed in triplicates.

3.2.9 Osteogenic marker expression (Alkaline phosphatase (ALP) activity)
The ALP activity of cells seeded on mineralized and unmineralized scaffolds was quantified by
measuring the specific conversion of pNitrophenylphosphate (pNPP) to pNitrophenol (pNP). Briefly, at
the specified time points which would show the peak ALP activity, days 1, 3, 7, 10, and 14, the cells on
the scaffolds were lysed using a standard lysis buffer (Agilent Technologies). 50 µl of the cell lysate
was incubated with 50 µl of pNPP for 1 hour. After 1 hour, 50 µl of the stop solution (2M NaOH), was
added and mixed for 2 minutes. The values were then determined using a SPECTRAmax Plus plate
reader and read at 405 nm. Four samples for each group were assessed and the samples were each
analyzed in triplicates.

3.2.10 Statistics
All data presented are expressed as mean ± standard deviation (SD). Statistical analysis was performed
using the SPSS 15.0 software package (SPSS/PC Inc.) Data was analyzed using Student’s t-test in order
to determine a significance difference. Data was considered statistically different if p≤ 0.05. n=4 was
used for all studies unless otherwise indicated.
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3.3 Results
3.3.1 Surface characterization
Representative SEM images of the highly-aligned unmineralized and mineralized scaffolds are shown in
Figures 3.2A and 3.2B, respectively. Image analysis software was used to determine the average
diameters for the optimized nanofibrils, which were determined to be 0.66 ± 0.17 μm for the
unmineralized fibrils and 0.90 ± 0.11 μm for the mineralized fibrils (30 min NaOH treatment and 24
hour SBF treatment) (Figure 3.3). Analysis of the fibril alignment was also conducted and it was
determined that the average angular deviation of the nanofibrils for the aligned scaffolds is 3.89°
(Figure 3.4). In order to determine the proper mineralization parameters, SEM images of all treatment
groups were observed (Figure 3.5). Figure 5 shows images of representative scaffolds for all time
points of the surface hydrolysis and mineralization treatments. A mineral coating was observed on all
groups of the treated nanofibrils, though the scaffolds hydrolyzed for 30 min and mineralized for 24
hours were observed to have the most biomimetic coating, and therefore considered the optimal
treatment parameters (see Figure 3.6 for high magnification images). It was observed that this group
contained 150 nm particles on the surface of the PCL fibrils. Most of the other time points created
coatings that were either too thick, in which the HA nanoparticles either all joined together and formed a
thick coating containing a lot of agglomerations, or too thin of a coating, in which not enough HA
particles were present to significantly enhance the chemical, physical, and mechanical properties of the
scaffold. The thick agglomerations can most notably be seen on all of the scaffolds that were incubated
in 5X SBF for 36 hrs. The samples that were treated for shorter periods of times, including those that
hydrolyzed for 15 minutes and incubated in SBF for 12 hrs, seemed to have a more sparse coating. As
the treatment times got closer to the optimal times determined (30 min NaOH, 24 hrs SBF), a more even
coating was seen. XPS (Figure 3.7) data confirmed that as the hydrolysis times increased, a linear
increase in the area under the curve for C-OH bonds was seen, though it leveled off at 45 minutes. The
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value for the control group (0 minutes) was used as a baseline value, as some C-OH bonds may be
present, but also due to the similar binding energy as the C-O-C bond. This data further confirmed the
superiority of a 30 minute hydrolysis time, as the 45 minute time period did not further increase the
amounts of C-OH groups present on the surface.

A

B

Figure 3.2: Highly-aligned unmineralized (A) and mineralized (B) PCL nanofibril scaffolds; Insets
show higher magnification images (10,000X)
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Figure 3.3: Average fibril diameters of 100 different fibrils from representative unmineralized and
mineralized scaffolds
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Figure 3.4: Mean angle of 100 different fibers from a representative nanofibril scaffold. The average
angular deviation was found to be 3.89º
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Figure 3.5: SEM images of all times points of hydrolysis treatment with NaOH (15 min: A, D, and G,
30 min: B, E, and H, 45 min: C, F, and I) and mineralization treatment with SBF (12 hrs: A, B, and C,
24 hrs: D, E, and F, 36 hrs: G, H, and I)
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Figure 3.6: High magnification SEM images of 30 min NaOH, 24 hour SBF treatment group; 5,000X
(A) and 15,000X (B)
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Figure 3.7: XPS data demonstrating increased amount of C-OH bonds with increasing hydrolysis time;
0 minutes (A), 15 minutes (B), 30 minutes (C), 45 minutes (D), and integral of C-OH curves at all time
points (E)
3.3.2 Elemental composition determination
EDS was used to determine the elemental composition of the optimized mineralized scaffolds, which
were created by first hydrolyzing the surface of the nanofibrils arrays for 30 minutes and then immersing
in SBF for 24 hours. Figure 3.8A is an energy spectrum illustrating the elements present at a specific
representative site of the mineral coating on the fibrils. Table 3.1 reveals the composition of the mineral
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coating at this site, in wt%. This coating exhibited a Ca/P ratio of 1.51, a similar value to the Ca/P ratio
of the hydroxyapatite found in natural bone, which is lower than a theoretical stochiometric Ca/P ratio of
1.67, since biological hydroxyapatite is usually calcium-deficient. High concentrations of both carbon
(C) and oxygen (O) were also observed, as expected, due to their presence in the polymer. Very low
concentrations of magnesium (Mg) were also seen, which was present in the SBF used to coat the
nanofibrils. However, ion substitutions are abundant and Mg is often seen in natural hydroxyapatite
[41]. Elemental mapping (Figure 3.8B) was also conducted in order to determine the location and extent
of the coating, and it was observed that the calcium and phosphorus present on the scaffolds aligned
completely and entirely on the nanofibrils and was not present elsewhere. XRD analysis was also
performed in order to further confirm the presence of hydroxyapatite. From this representative graph, a
peak can be seen at 32°, which is the most intense peak in the hydroxyapatite spectrum, confirming the
presence of hydroxyapatite in the samples (Figure 3.9).
A

B

Figure 3.8: Energy spectrum illustrating elements present in mineral coating on fibrils (A), A
representative element mapping of mineralized scaffolds (B)
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Table 3.1: Elemental composition at representative area of coating (wt %)
Element
Relative
amount

C

O

Mg

P

Ca

Total

49.38

36.97

1.11

5

7.54

100

Figure 3.9: XRD spectrum demonstrating the most intense peak in the hydroxyapatite spectrum (at 32º)
for the experimental samples (top) as compared to the control (bottom)

3.3.3 Tensile testing
Mechanical tensile testing was conducted in order to determine if the mineral coating on the nanofibrils
enhanced the scaffolds’ mechanical properties. Only tensile testing was conducted, as the samples were
not 3D and unable to be compressed. A macroscopic image of a nanofibril scaffold in the paper frame
for mechanical testing can be seen in Figure 3.10. The samples were all constantly strained at
deformation speed of 2.5 mm/min, which was determined from previous unpublished data, until
mechanical failure. From this set of data, the stress, strain, modulus, and toughness were determined for
each sample. Mechanical tensile data shows significantly enhanced mechanical properties, such as
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elastic modulus, ultimate strength, and toughness for the mineralized fibrils, as compared to the
unmineralized controls (Figure 3.11). Further, the ultimate strain of the mineralized scaffolds showed
no significant difference from the unmineralized scaffolds, and at times was greater for the mineralized
group. This high elasticity along with the increased strength demonstrated by the mineralized scaffolds
makes them an excellent candidate for bone tissue engineering applications. Figure 3.11 shows
representative stress-strain curves comparing the unmineralized scaffolds and the mineralized scaffolds
(A), as well as the mechanical properties for both groups (B). Values can also been seen in Table 2.

Figure 3.10: Image of 2D nanofibrous array in paper frame for mechanical testing. Red dotted lines
indicate where a cut was made after loading into tensile tester

Table 3.2: Mean mechanical properties of representative mineralized and unmineralized scaffolds
Diameter

Modulus

Ultimate Strength

Ultimate Strain

Toughness

(μm)

(MPa)

(MPa)

(%)

(MPa)

Unmineralized

0.66 ± 0.17

348.75 ± 66.56

89.52 ± 27.38

131.75 ± 28.43

66.47 ± 25.06

Mineralized

0.90 ± 0.11

602.12 ± 117.58

200.39 ± 74.69

144.92 ± 15.97

163.86 ± 53.31
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Figure 3.11: Representative stress-strain curves of mineralized and unmineralized nanofibril arrays (A)
and graph of mechanical properties (B)

3.3.4 HEPM cell attachment/alignment
Confocal microscopy images of the HEPM cells cultured on mineralized and unmineralized scaffolds
were taken on day 5 of culture. The actin was stained with Phalloidin 488, and shown in green, and the
nucleus was stained with DAPI, and shown in blue. The aligned nanofibrils were not stained but can be
visualized with the alignment of the cells. The cells on both scaffolds were observed to be very
elongated in the direction of the fibrils. Observing Figure 3.12, it can be seen that cells attached and
aligned just as well on the mineralized fibers as compared to the unmineralized controls. No significant
difference can be seen between the two groups.
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A

B

50 µm

50 µm

Figure 3.12: Cell attachment and alignment on mineralized (A) and unmineralized (B) aligned scaffolds
at day 5 of culture
3.3.5 HEPM cell proliferation
From results of an alamar blue assay, no cytotoxicity was observed from the mineralization treatment.
Further, results of the alamar blue assay indicate similar proliferation rates for the mineralized scaffolds
as compared to the unmineralized control scaffolds after 1, 3, 7, 10, and 14 days of culture (Figure
3.13), showing no effect of the mineralized nanofibrils on cell proliferation.
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Figure 3.13: Alamar blue assay for HEPM cell proliferation on mineralized and unmineralized
nanofibril scaffolds. n= 2 per group. Bars represent mean standard deviation. No difference was seen
between each treatment on the given days
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3.3.6 Osteogenic marker expression - Alkaline phosphatase (ALP) activity
An ALP activity assay was performed in order to assess the differentiation of the HEPM cells into
osteoblasts on the mineralized scaffolds, as compared to the unmineralized control scaffolds. As
previously reported, it was predicted that the mineralization on the scaffolds would induce the
osteoprogenitor cells to differentiate into osteoblasts [42]. Results of a 14 day study indicate enhanced
ALP activity of cells seeded on the mineralized scaffolds on days 10 and 14 of culture, when compared
to cells on unmineralized scaffolds (Figure 3.14). These results are significant as they show that the
biomimetic HA coating on the scaffolds induced osteoprogenitor cells to differentiate towards an
osteoblast lineage.
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Figure 3.14: ALP activity assay for HEPM osteogenic differentiation on mineralized and unmineralized
nanofibril scaffolds. Bars represents mean standard deviation. Enhanced ALP activity was seen on days
10 and 14 with the mineralized scaffolds
3.4 Discussion
The key premise and promise of bone tissue engineering is mimicry of bone development or in
vivo bone healing. The hallmarks of this healing cascade are angiogenesis, cell recruitment, and
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osteogenic differentiation. Notably, this cascade can be well-supported by biomimetic scaffolds having
tailored surface chemistries and topographies to support the osteogenic and osteoinductive processes that
are fundamental to bone tissue regeneration. Indeed, regulation of these processes is mediated by microenvironmental influences such as resident cell populations, orchestration of biomolecule sequestering
and release, and cell-matrix interactions. To date, existing materials lack appropriate osteoguidance and
structural cues that are necessary for regeneration of long bone, which is optimized to perform loadbearing functions. This is particularly true for the regeneration of cortical bone which is characterized by
its highly-organized structure. Therefore, it is desirable to develop bone regeneration scaffolds which
harness the merits of existing biomimetic materials and are strengthened by incorporation of
osteoguidance cues to induce cortical bone regeneration. To this end, we are aiming at developing a
highly-aligned fibrous scaffold that incorporates biomolecule and structural cues for cortical bone
regeneration in long bone defects. The scaffold joins the physical and biological merits of conventional
biomaterials for bone tissue engineering with a unique structural attributes for directional bone
regeneration. When implanted in vivo, this scaffold may facilitate mesenchymal stem cell (MSC)
recruitment onto the scaffold composed of highly-aligned biomineralized degradable fibril arrays to
regenerate the bone in defect sites. Arrays of nanofibrils further build in the property of microporosity,
which allows for exchange of nutrients and waste. In the future, by synergistically nesting osteoguidance
and bioactive cues with a 3D version of these biomimetic fibril array-based scaffolds, the potential to
direct regeneration of functional cortical bone may exist.
The first step towards achieving this goal is to create biomimetic, highly-aligned, electrospun
polymer/ceramic composite nanofibrous arrays, which were developed in this study. The highly aligned
nanofibrils were fabricated by a motorized parallel plate electrospinning technique developed in our lab.
These aligned nanofibrils had an average angular deviation of only 3.89º, with most of the fibrils being
within ±10º. Others who claim a high degree of alignment of their nanofibers report angular deviations
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and ranges that are much greater [23, 43]. Alignment is particularly important in this application, as it
has been shown to guide cell growth, as well as enhance proliferation of osteoprogenitor and other cells
[44-46]. These aligned scaffolds were then mineralized using a biomimetic technique in order to create
an osteoconductive and bioactive scaffold. The optimal mineralization parameters (NaOH treatment for
30 minutes and SBF treatment for 24 hours) were determined in this study, in which a Ca/P ratio of 1.51
was achieved for the coating. This value is slightly lower that the stochiometric value, but very similar
to the the Ca/P ratio of biological hydroxyapatite found in natural bone [47]. As it is widely known that
hydroxyapatite forms in the gap zones of collagen fibrils and elongates on the fibrils, it is now thought
that this distinct structure in the very lowest hierarchical level of bone provides it with its excellent
mechanical properties. Some now believe that the great strength and toughness of bone actually has to
do with not only the small size of the hydroxyapatite crystals, but also the gaps in between them [48].
The stacked, alternating structure of 300 nm long collagen fibrils between hydroxyapatite crystals is
believed to provides bone with a “yield region” in which a small portion of the bone is allowed to
stretch, thereby spreading the applied pressure over a greater area and rescuing the integrity of the entire
structure [49]. Though it is impossible to exactly mimic the remarkable microstructure of bone, it is
apparent that achieving a similar microstructure, in which small HA crystals are separated by a small
“yield region” would be ideal. This hypothesis is supported by our mechanical testing data, in which
our mineralized scaffolds, which possessed a “yield region” on a similar scale (as small as 25-50 nm),
not only demonstrated enhanced ultimate strength, modulus, and toughness, but maintained its elasticity
as well. This is believed to be true based on the scaffolds in this study possessing biomimetic, evenlydispersed, strongly-attached hydroxyapatite crystals with an average diameter of about 150 nm that were
formed on the surface of the nanofibrils (see Figure 3.6). The small size of these crystals, along with
the small spaces between in crystal, more closely mimicked the microstructure of bone by allowing for a
“yield region” which provided for great strength and toughness. Both of these characteristics are very
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important for bone tissue engineering scaffolds, as bone has to bear loads, but also absorb shock. As
expected, the mechanical properties of these scaffolds were significantly enhanced, demonstrating much
improved ultimate strength, as well as a similar ultimate strain. By creating a “more” biomimetic bone
scaffold, not only were the mechanical properties significantly improved, but a more osteoconductive
and bioactive scaffold was produced. The osteoprogenitor cells demonstrated excellent attachment,
alignment, proliferation, and ALP activity when seeded on the mineralized scaffolds, indicating that
theses scaffolds could be an excellent choice for bone regeneration applications. Though these
attributes were not significantly enhanced based on the unmineralized controls in vitro, it is important to
note that the scaffolds still performed exceptionally and when implanted in vivo, the enhanced
osteoconductive nature of the scaffolds would come into play. By closely mimicking the natural bone in
both structure and composition, it is expected that, in vivo, these scaffolds will regenerate a bone that is
more similar to natural bone. This work is novel in this regard, as no other studies have attempted to
mimic natural bone to this level.
Based upon the principles of tissue engineering and biomimicry, a highly-aligned mineralized
nanofibril arrays would not only reserve the native bone structure at the lesion site, but also constitute a
framework for the regeneration of new bone for functional restoration. In addition, the nanofibrous
scaffold possesses the properties necessary to support bone tissue regeneration including
biocompatibility, controlled degradability, mechanical integrity, osteoconductivity, and excellent bone
guidance ability. Future preclinical studies will investigate the effect of scaffold morphology on new
ECM organization as well as incorporate of certain growth factors in order to further enhance bone
regeneration and promote vascularization. As current strategies have yet to produce a suitable candidate
for a clinical cortical bone substitute, this strategy has a great deal clinical relevance, as it can potentially
serve as an alternative to autologous bone grafts.
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3.5 Conclusion
This study has been successful in developing biomimetic mineralized coating on polymer
nanofibrous scaffolds. The ceramic coating allowed for a scaffold that has significantly enhanced
mechanical properties, osteoconductivity, and bioactivity, which are all very important qualities for a
bone tissue engineering scaffold. HEPM cells exhibited no cytotoxicity and demonstrated excellent cell
attachment, alignment, proliferation, and ALP activity on these scaffolds. These in vitro result show
promise for future studies in which biomolecules will be incorporated into 3D scaffolds for in vivo bone
regeneration applications.
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CHAPTER 4
INVESTIGATION AND CHARACTERIZATION OF HIGH SURFACE AREA STARSHAPED MICROFIBERS FOR USE IN TISSUE ENGINERING APPLICATIONS

4.1 Introduction
The use of star-shaped microfibers for tissue engineering applications is a relatively new
concept which hasn’t been demonstrated a great deal in the literature. There are a few reports of
“grooved” or “lobed” fibers suggested for tissue engineering applications [1, 2], in which the
researchers have shown that the atypical shape has contributed to enhanced surface area. Others
have merely characterized atypically shaped fibers, but have not suggested potential applications
[3, 4]. To our knowledge, only one other group has actually tested atypically shaped fibers for
potential use in tissue engineering applications. This groups characterized their “corrugated”
fibers and then tested them in vitro for enhanced cell attachment and cell proliferation [5].
However, this group studied cell attachment and proliferation based on static and dynamic
culture, and could not directly correlate the cell behavior to fiber shape or surface area.
As high surface area is often a very desirable quality for tissue engineering scaffolds, it
makes sense that scaffolds can be designed with a similar morphology to fit this application.
Increasing the surface area of a tissue engineering scaffold is beneficial on multiple levels. For
one, and most importantly, it allows more space for cells to attach and spread in order to begin
synthesizing new extracellular matrix (ECM). Many have shown that there is a direct correlation
between scaffold surface area and cell attachment, as well as cell viability, proliferation, and
differentiation [6-10]. Increasing the amount of cells that will attach to the scaffold will thus
enhance the ability for ECM to be produced and the tissue to be regenerated [11, 12]. Other
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benefits of the increased surface area provided by star-shaped fibers for tissue engineering
scaffolds include enhanced protein adsorption [13], increased ability to load drugs [14-16], as
well as the ability to aid in the transport of fluids [1], such as nutrients and waste.
When characterizing fibers in general, the surface area is referred to in terms of specific
surface area (SSA), which is the surface area per unit volume. Another important parameter
when characterizing fibers is its shape factor. Shape factor is defined as the ratio of the
perimeter of a distinctly shaped fiber to that of a round fiber of equal denier [2], which is a linear
mass density of fibers. However, often, in tissue engineering applications, the shape factor is
often considered by simply comparing diameter/circumference of the fibers when round or the
perimeter when it is an atypical shape. These values can be directly correlated to the surface area
of the fibers. However, oftentimes, the surface area-to-volume ratio is the only factor necessary
to evaluate and compare the fibers surface area [10, 15]. This characteristic is very important
for tissue engineering scaffolds, as mentioned above, as a higher surface area-to-volume ratio has
been shown to promote cell attachment, proliferation, differentiation, and new ECM secretion.
Based on the above knowledge, it was our aim to investigate the use of star-shaped
microfibers for tissue engineering applications. These star-shaped microfibers could be
fabricated with varying sizes and shapes to fit the specific application. Grooves were
incorporated onto the arms in order to further increase the surface area of the fibers and allow for
enhanced cell attachment. The grooved, star-shaped microfibers where characterized in depth in
order to ensure they possessed the appropriate qualities for use in tissue engineering applications.
The star- shaped microfibers were compared to round controls of equivalent cross sectional area
for normalization purposes. This would ensure that the volume of the fibers for a specific length
is held constant in order to accurately compare the surface areas. SEM images were taken in
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order to closely observe the surface and cross section of the fibers as well as make surface area
calculations. The tensile mechanical properties were measured and analyzed. In vitro studies
were conducted to assess cell attachment and viability/proliferation on the star-shaped fibers.
Preliminary data indicated that these fibers were excellent candidates for use in tissue
engineering applications. In the future, these fibers could be used in conjunction with other tissue
engineering scaffolds in order to mimic 3D aligned tissues as well provide enhanced surface area
and porosity.

4.2 Materials and Methods
4.2.1 Materials
Polypropylene (PP), Isostatic was obtained from Sigma Aldrich (St. Louis, MO).
4.2.2 Fabrication of round and star-shaped PP microfibers by hot melt extrusion
Star –shaped and round PP fibers were fabricated by hot melt extrusion. The device utilized to
produce these fibers was custom designed in our lab (Figure 4.1A). A modified syringe pump
was used to push a metal plunger at a rate of 1.5 mL/min into a metal vessel containing the
molten PP. This vessel was heated above the polymers melting point (210 °C) in order to ensure
the polymer was completely molten. The bottom of the vessel contained a removable die that the
fibers were extruded out of. Two different dies were used for this study: one for the round fibers
and one for the star-shaped fibers (see similar dies in Figure 4.1B). The round die was 500 µm
in diameter and the grooved, star-shaped die was 600 µm in diameter, including the length of the
arms. Once the polymer was extruded out of the die, it was collected on a rotating plastic
cylinder. Various rotation speeds were assessed in order to get the desired fiber diameter (data
not shown). The fiber diameter was based on achieving similar cross sectional areas of the
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different fiber types. From this initial test, we determined that a rotation speed of 180 rpm
formed 107.41± 5.16 µm diameter round microfibers and a rotation speed of 190 rpm formed the
star-shaped fibers with the outer diameter of 171.70±7.30 µm.

A

B

Figure 4.1: Custom fiber extruding device designed in our lab (A), dies used to create round
(left) and star-shaped (right) fibers (similar larger star-shaped dies are shown to reveal shape and
texture) (B)

4.2.3 Characterization
4.2.3.1 SEM
Scanning electron microscopy was utilized in order to evaluate the morphology and assess the
dimensions of the grooved, star-shaped microfibers and round controls. A JEOL LV-5610 SEM
was used at an accelerating voltage of 20 kV and a working distance of 20 mm for this study.
The SEM was used to characterize the topography of the fibers and assess their uniformity.
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Also, SEM images, along with image analysis software (ImageJ), were utilized to attain the
average dimension of each component of the fibers in order to use for surface area calculations.
4.2.3.2 Surface area calculations
The surface area of the grooved, star-shaped microfibers and round control microfibers was
assessed using the dimensions acquired from the images analysis software and SEM images. To
do so, the perimeter/circumference of each group was determined. For the star-shaped fibers, the
perimeter was calculated using the following formula: P = (8*AW) + (8*DA) + (16* AL) (see
Table 4.1 for abbreviations). The circumference of the round control fibers was easily
calculated using the formula: C= πd. From these values, the surface area could easily be
correlated, and could be determined with a given sample length.

4.2.4 Mechanical testing
The tensile mechanical properties of grooved, star-shaped microfibers and round controls were
obtained using an EZ Graph tensile tester (Shimadzu Corporation). Five scaffolds were tested
for each group. 25 mm long scaffolds were constantly strained at a rate of 5 mm/min until
mechanical failure. The cross sectional areas utilized were determined from the SEM images
above. The force/displacement data was analyzed and used to calculate stress (MPa) and strain
(%) values. The modulus was determined by analyzing the graphs between 0 and 5% strain.
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4.2.5 In vitro studies
4.2.5.1 Attachment
Human embryonic palatal mesenchymal (HEPM) stem cells (ATCC) were seeded onto the
grooved, star-shaped and round control microfibers in order to assess cell attachment. Each fiber
type was first formed into a bundle of twenty 1 cm long fibers for the cells studies. 4 bundles
were made for each group. HEPM cells were cultured until P4 and then passaged and seeded
onto each scaffold at a density of 5 x 103 cells/scaffold. To do so, the cells were suspended at a
very high concentration in growth medium (alpha minimum essential medium (αMEM)
supplemented with 10% fetal bovine serum and 1% antiobiotic) and carefully dripped onto the
scaffolds. After one hour, in which cells were allowed to establish initial attachments to
scaffolds, the scaffolds were completely covered with media (about 1.5 mLs in a 12 well plate)
and maintained in an incubator at 37ºC with 5% CO2 . Attachment was analyzed after 12 hours
in vitro. To do so, the scaffolds were removed from the wells they were housed in and placed in
other media containing wells to separate from cells that may have attached to the bottom of the
wells instead of the fibers. The fibers were then rinsed with media once and then trypsinized.
The cells were resuspended and counted. This number was compared to the amount of cells
initially seeded to determine an attachment percentage.
4.2.5.2 Cell viability/proliferation
In order to assess scaffold toxicity as well as cell viability and proliferation, a cell titer blue assay
was performed. HEPM cells were cultured and seeded as described above. However, based on
results of the attachment study, cells were seeded at different concentrations to ensure that equal
cells were initially attached to the scaffolds at the beginning of the study. This was done to
ensure that only viability and proliferation were being assessed, and that they weren’t affected by
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the initial attachment of the cells. HEPM cells were also cultured on round microfibers with
equal cross sectional areas, as positive controls. The cell titer blue assay was performed on days
1, 3, 7, 10, and 14. On the given days, the growth media was removed from the wells and was
replaced with the cell titer blue reagent (5:1 growth media:Cell titer blue reagent). The cells were
allowed to incubate in this reagent for 4 hrs. After 4 hrs, then reagent was removed and saved.
The cells were washed with additional media before replacing with the media and incubating the
cells at 37 °C and 5% CO2 until further use. The collected reagent was pipetted into a 96 well
plate in triplicates and the relative fluorescence intensity was measured using a BioTek Synergy
H1 Hybrid plate reader, measured at an excitation of 560 nm and an emission at 590 nm.

4.2.6 Statistics
All data presented are expressed as mean ± standard deviation (SD). Statistical analysis was
performed using the SPSS 15.0 software package (SPSS/PC Inc.) Data was analyzed using
Student’s t-test in order to determine a significance difference. Data was considered statistically
different if p≤ 0.05. n=4 was used for all studies unless otherwise indicated.

4.3 Results
4.3.1 SEM images
The grooved, star-shaped microfibers and round control fibers were characterized extensively
with the SEM. The fibers were highly consistent, uniform, and demonstrated defined
characteristics. A smooth topography for both fiber types was observed. Fibers with varying
diameters, arm configurations, and groove could be utilized for this application and parameters
could be tailored for specific applications. The fibers we characterized had an overall star-shaped
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morphology that contained a circular core with 8 arms (Figure 4.2). Each arm had 4 distinct
grooves. Precise dimensions were determined using image analysis software (Image J) on a
representative image. Average dimensions were determined from taking five measurements of
each feature and taking the average. The specifically designed star-shaped fibers fabricated for
this study had an average central diameter of 70.41 ± 2.25 µm, extending to an average of 171.70
± 7.30 µm when including the arms. Dimensions of the grooves on the arms were 14.07 ± 1.38
µm in length with the whole arm averaging 50.36 ± 5.70 µm. The thickness of each arm was
13.02 ± 1.49 µm. Also, the space between the arms averaged 16.34 ± 2.65 µm (see Table 4.1
for a complete list of dimensions). The round control fibers had a diameter of 107.41 ± 5.16 µm
to closely match the surface area of the star-shaped microfibers.

A

B

C

D

Figure 4.2: Cross sectional view (A and C) and side view (B and D) of grooved, star-shaped
microfiber and round controls, respectively
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Table 4.1: Dimensions of Star-Shaped fibers
Length (µm)

Feature
Central diameter (CD)
Total diameter (TD)
Arm length (AL)
Arm width (AW)
Distance between arms (DA)
Groove length (GL)

70.41 ± 2.25
171.70 ± 7.30
50.36 ± 5.70
13.02 ± 1.49
16.34 ± 2.65
14.07 ± 1.38

4.3.2. Surface area calculations and comparisons
The average surface area of the grooved, star-shaped microfibers was determined and compared
to round controls. The dimensions measured from SEM images were utilized. From this data,
we aimed to calculate the perimeter in order to correlate to the available surface area for cell
attachment. From these calculations, it was determined that the perimeter of the star-shaped
microfibers are on average 1040.66 µm and possessed a cross sectional area of 9139.16 µm2.
Comparing these fibers to round fibers with a similar cross sectional area (diameter=107.41 ±
5.16 µm), the perimeter/circumference would be 337.43 µm on average, which is less than a
third of the star-shaped microfibers (Figure 4.3). These perimeter/circumference values can be
directly correlated to surface area of the fibers, given a specified fiber length. The enhanced
surface area of the star-shaped microfibers would theoretically allow for 3 times as many cells to
attach to the fibers. In the future, these fibers can be fabricated into bundles to form 3D tissue
engineering scaffolds, in which the added surface area will allow for excellent cell attachment.
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Figure 4.3: Comparison of perimeter of star-shaped microfibers to circumference of round
microfibers to assess available surface area

4.3.3 Mechanical testing
The tensile mechanical properties of the grooved, star-shaped fibers were determined and
compared to round controls. Five samples for each fiber type were tested, which were only
tested in tension, as they were unable to be tested in compression. The samples were deformed
at a rate of 5 mm/min until failure. Using known cross sectional areas and gauge length, the
stress and strain could be calculated. The stress-strain curves for representative round and starshaped microfibers can be seen in Figure 4.4. As expected, the round microfibers demonstrated
a superior maximum stress when compared to the grooved, star-shaped fibers, as this shape has
been known to be mechanically superior. As the star-shaped microfibers were atypically shaped,
containing numerous edges and corners, we predicted that the tensile properties would be lower
due to stress concentrations. Significant necking was observed in the star-shaped microfibers
after considerable deformation, which we believe occurred due to the stress concentrations,
though this did not lead to premature failure. The ultimate stress of the representative star-
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shaped fiber, which was most similar to the average ultimate stress, was 310.07 MPa whereas the
ultimate stress of the representative round fiber was 514.40 MPa. However, both samples were
highly elastic, demonstrating similar ultimate strains exceeding 250%. The elastic modulus was
considerable for both samples, as well, with an elastic modulus for the round microfibers of 9.49
GPa as compared to 6.16 GPa for the star-shaped microfibers.
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Figure 4.4: Stress-strain curve of representative grooved, star-shaped microfibers (blue) and
control round microfibers (red)

4.3.4 In vitro results
4.3.4.1 Attachment
Cell attachment was assessed 12 hours after seeding on grooved, star-shaped fibers and control
round fibers, to allow time to attach but not enough time for the cells to proliferate. This was
done by dripping a highly concentrated cell solution directly onto the fiber bundles. After 12 hrs,
cells were detached using trypsin and counted to assess the extent of attachment. Based on the
seeding density, the percent attached was calculated for each group. Results indicate
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significantly more cells attached to the star fibers, with 55 ± 13.71% of cells attaching, whereas
only 20 ± 5.16% of cells attached to the round fibers (Figure 4.5).
4.3.4.2 Viability/Proliferation
HEPM cell viability and proliferation on the round and star-shaped scaffolds was assessed using
a cell titer blue assay. Cells were cultured and seeded as described above, and the assay was
performed on days 1, 3, 7, 10, and 14. As initial attachment was controlled to have even
numbers, the similar viability on days 1 and 3 are expected. The cells continued to proliferate at
a steady level on days 7 and 10. However, at this point, the proliferation of the cells on the
round fibers seems to plateau, indicated by the significantly enhanced cell numbers on day 14
(Figure 4.6). This establishes that these scaffolds are not only non-toxic, but also confirms that
these scaffolds promote viability and proliferation of the cells. Also, since the only difference
between the two scaffolds was the shape and surface area, it can be further deduced that these
parameters promoted the enhanced viability and proliferation of the preosteoblasts on day 14.
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Figure 4.5: HEPM cell attachment on star-shaped and round microfibers
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Figure 4.6: HEPM cell proliferation on round and star-shaped microfibers

4.4 Discussion
In this study, it was our aim to investigate and characterize star-shaped nanofibers for use
in tissue engineering applications. Round and star-shaped fibers were created that were highly
uniform and precise. Various shapes, sizes, and structures could be fabricated using this method
and could be tailored based on the application. The greater surface area provided by the atypical
shape of the star-shaped fibers can be exploited in order to improve cell attachment,
proliferation, differentiation, and ECM secretion [6-10]. To our knowledge, no one has used starshaped fibers for tissue engineering applications. Though a few other large surface area fibers
have been used in this regard, the surface area attained is still significantly smaller, possessing
shape factors in the range of 2.3 to 2.8 [2]. These values correlate with considerably lower
surface areas than our fibers, which have an average shape factor of 3.08. This additional
surface area makes a great difference, contributing many advantages for tissue engineering
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scaffolds, including enhanced cell attachment, protein adsorption, drug loading ability, and fluid
transport [1, 13-16].
The tensile mechanical properties of the star-shaped fibers and round controls were
assessed. Both fiber types exhibited significant elasticity, deforming over 250% of their original
length. This is extremely significant when designing a scaffold for tissue engineering
applications, as many of the tissues in the body are highly elastic [17-22]. Further, many
different tissue in the body, including bone, have extracellular matrix (ECM) proteins that are
fibrillar and form an aligned structure. Mimicking the mechanical properties and structure of the
tissue that is being regenerated is very important in order to guide cells and new tissue growth
[23-25]. Though the average ultimate stress of the star-shaped fibers was significantly lower than
that of the controls, we do not suspect this will be an issue as these fibers still exhibited excellent
tensile ultimate stress and modulus.
Preliminary in vitro studies confirmed our hypothesis that significantly more cells would
attach onto star-shaped fibers as compared to round controls with similar cross sectional areas.
Similarly, cell proliferation on these fibers at later time points was also enhanced when
compared to controls, which was most likely due to the enhanced surface area which provided
added space for cells to proliferate on. Others who have fabricate atypically shaped fibers with
enhanced surface area have seen similar results [1, 5].
For tissue engineering applications, a diverse array of fiber types have been investigated
for the use in the regeneration of a range of tissues in the body. These tissues often consist of
structures that are characterized by aligned extracellular matrix proteins. This distinguished
structure is very important in order to provide the necessary properties for these tissues to serve
their intended function. However, when these tissues become diseased or injured, intervention
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must take place. With tissue engineering strategies gaining much interest in actually
regenerating these specific tissues once diseased, mimicking this structure has become the
ultimate goal. Many aligned tissues including, but not limited to, neural tissues [26-28], vascular
tissues [29, 30], skeletal muscle [31, 32], bone [23, 33, 34], cartilage [35-37], ligaments [38, 39],
tendons [40], and many others, have been investigated using an aligned fiber tissue engineering
approach. This research area focuses on creating highly aligned natural or synthetic polymer
nanofibers in order to serve as a matrix for cells to regenerate the aligned native tissue. By
mimicking the native structure as closely as possible, regeneration of the tissue will be more
effective. The basis behind this idea is that the synthetic scaffold will serve as a template for the
cells to attach and align on, therefore guiding the new ECM produced to align as well. In the
future, it is our goal to create a 3D aligned scaffold, utilizing the star-shaped microfibers, in
order to more effectively regenerate various aligned tissues in the body. We believe that the
added surface area of these fibers will allow for better growth factor incorporation, protein
adsorption, and cell attachment but also provide the aligned template to ultimate regenerate the
tissue more effectively. Further, we also believe that contact guidance cues provided by these
micro scale fibers could also enhance cellular response.

4.5 Conclusions
In this study, grooved, star-shaped microfibers were investigated for their potential for
uses in tissue engineering applications. The superior surface area of these microfibers allowed
for significantly enhanced cell attachment and viability when compared to round controls. In the
future, these fibers can be used in conjunction with other tissue engineering techniques to aid in
the fabrication of a biomimetic tissue engineering scaffold with enhanced surface area and tissue
regeneration capabilities.
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CHAPTER 5
THE USE OF HIGHLY POROUS CERAMIC CONSTRUCTS FOR CANCELLOUS
BONE TISSUE ENGINEERING

5.1 Introduction
Bone tissue engineering has emerged as the future option for the treatment of critical
sized bone defects [1, 2]. Though allografts and autografts are still the gold standard [3-5], there
are many clinically available bone regeneration strategies on the market [6-8]. There are various
approaches in this field that have gained distinction due to recent advances and milestones
reached. Amongst these approaches, a variety of scaffold types are utilized, including coralderived scaffolds [9-13], sponge-like polymer scaffolds[14-16], injectable biomaterials [17-19],
and highly porous ceramic scaffolds [20-24], to name a few. Highly porous ceramic constructs
are often used in the field of bone tissue engineering, as they have a very similar composition
and structure to that of human cancellous bone [24]. They are very easy to make and often
possess many excellent qualities, such as biocompatibility and bioactivity. Further, the
interconnected pores of these scaffolds provide a high surface area for cell infiltration and
attachment as well as room for vascularization and new tissue ingrowth [21, 25]. Nevertheless,
when fabricating this type of scaffold, many factors need to be considered, including material
selection, porosity, mechanical properties, and degradation [25-27].
Porosity is a very important consideration when designing a scaffold for bone tissue
engineering, as bone will not be able to regenerate if cells can’t infiltrate the scaffold or if new
tissue cannot grow into the space that the scaffold is residing in. It is widely agreed upon that
pore sizes exceeding 100 µm in diameter is necessary to allow for new tissue ingrowth and
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vascularization, though many agree that larger pore sizes, exceeding 300 µm, is ideal [28-30].
However, as the porosity of the scaffolds increase, mechanical properties are significantly
affected, often diminishing exponentially [31]. Though some have investigated the use of tissue
engineering scaffolds with low porosity and better mechanical properties [32], most choose the
contrary when attempting to regenerate bone. In this case, the mechanical properties of the
scaffolds are often still suitable for non load bearing applications, with many scaffolds having
average ultimate strengths in the range of 1-10 MPa [27, 33-35]. These mechanical properties
are comparable to human cancellous bone, which has an average ultimate strength of 1-6 MPa
[36-39], though the mechanical properties of whole bone are far superior [39].
Another very important factor to consider is the biodegradability of the scaffold. In order
to actually regenerate the tissue, the scaffold must degrade as new extracellular matrix (ECM) is
produced to allow space for the newly formed tissue. The type of ceramic used, therefore, must
be taken into account. Stochiometric hydroxyapatite (HA) is often utilized, as it has a similar
composition to the mineral naturally occurring in bone, biological hydroxyapatite [40, 41].
However, stochiometric HA has some unfavorable characteristics for tissue engineering
applications, including minimal degradability [42, 43]. β-Tricalcium phosphate (βTCP) is also
widely used, as it has a similar Ca/P ratio as biologic apatite [42], and is biodegradable [43], but
may degrade too quickly in the body [35]. For these reasons, these two ceramics are more often
used jointly to form a “biphasic” structure, which in turn possesses enhanced properties, such as
degradability. These biphasic structures are often created with higher ratios of βTCP [20, 43]
and referred to as biphasic calcium phosphate (BCP) [43]. By altering the ratio of components,
the properties of the scaffold can be tailored based on the application.
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Keeping these factors in mind, it was our goal to create a highly porous scaffold that
mimicked the properties of human cancellous bone, including microstructure and composition.
Further, we aimed to create a scaffold that had enhanced porosity and a desirable degradation
rate in order to encourage the regeneration of new bone tissue that is more similar to that of
native bone. In this study, using a porogen leaching technique, we fabricated highly porous
ceramic scaffolds which were composed of 85% βTCP and 15% HA. This composition was
determined based on previous studies in order to mimic the composition of natural bone while
also allowing for optimal degradation and mechanical properties. The scaffolds were fabricated
to possess very high porosities, exceeding 80%, in order to promote cell infiltration and new
tissue ingrowth. For this reason, the mechanical properties were not ideal, though they would
work for non load bearing applications. However, in the future, these mechanical properties can
be improved upon by incorporating other types of materials, such as polymers, or by altering the
composition further. Preliminary cell studies indicated no cytotoxicity of the biomimetic
scaffolds. HEPM cells demonstrated excellent viability, proliferation, attachment, and migration
on the biomimetic scaffolds as compared to controls, indicating that these scaffolds would be
suitable for use in bone regeneration applications. The degradation profile of the scaffolds was
assessed in vitro in order to ensure the scaffolds degraded at a desired rate. Ongoing
experiments include the incorporation of polymer components to enhance mechanical properties
and further mimic the structure of whole bone. Growth factor incorporation, including bone
morphogenetic protein 2 (BMP2) and vascular endothelial growth factor (VEGF), is currently
being conducted. The release rates are being studied and the parameters are being adjusted to
achieve the desired release profile. Once optimized, these scaffolds will be implanted in vivo
and evaluated for bone regeneration capabilities and new ECM organization.
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5.2 Materials and Methods

5.2.1 Materials
Paraffin was purchased from Leica Biosystems Richmond, Inc. (Richmond, IL). Polyvinyl
Alcohol (PVA), β-Tricalcium phosphate (βTCP), Polyethylenimine (PEI), Sodium Hydroxide
(NaOH), and Hydroxyapatite (HA) were purchased from Sigma Aldrich (St. Louis, MO).
Carbomethylcellulose (CMC) was purchased from TCI Chemicals (Hong Kong, China). Ethanol
(EtOH) was purchased from Pharmco-Aaper (Brookfield, CT). 4',6-diamidino-2-phenylindole
(DAPI) and Phalloidin 488 were purchased from Life Technologies (Grand Island, NY).

5.2.2 Fabricating wax beads
Wax beads were fabricated using a conventional suspension method[44] (see schematic in
Figure 5.1). In short, paraffin was melted at 60 °C. Simultaneously, PVA was dissolved in
water at a concentration of 0.5% in a large beaker at 60 ºC. The melted wax was then poured
into the PVA solution under constant stirring at a low speed. Ice cold water was then poured into
the beaker to solidify the wax. The wax was removed from the PVA solution and dried
overnight before separating into varying sizes using standard sieves.

0.5% PVA
Heat to 60°C

Stir (low
speed)

Add melted
paraffin

Add ice
water

H2O

Figure 5.1: Wax bead fabrication via the conventional suspension method
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Dry and
Sieve

5.2.3 Slurry Preparation
The slurry was prepared based on the method demonstrated in Figure 5.2. Briefly, the CMC,
BTCP, and HA dry powders were mixed thoroughly. The water and PEI were then added and
mixed for an hour to ensure a uniform mixture was achieved. The mixture was used immediately
to avoid drying.

15% HA

85% β‐TCP

CMC

Dry Mix

H2O

PEI

Wet Mix

Figure 5.2: Step by step method to prepare ceramic slurry

5.2.4 Green Body Fabrication
The green bodies were fabricated using a porogen leaching method (see schematic in Figure
5.3). To do so, a 2 mL syringe was employed in order to apply a pressure that would allow the
slurry to penetrate the wax mold. The top was cut off to expose a hollow tube which could be
filled with the necessary components. First, the wax beads were poured into the top of the
syringe to cover about an inch of space. They were placed in an oven for 5 minutes at 60 ºC to
melt them together slightly, which would produce the interconnected pores in the green body.
The syringe was then removed from the oven and cooled slightly before adding the slurry. The
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top of the syringe was then placed on a rubber stopper and pressure was applied to the plunger in
order to drive the slurry into the wax mold. It was held down for 5 seconds. The stopper was
then removed and the slurry impregnated wax mold was pushed out of the syringe using the
plunger. The green body was allowed to solidify at room temperature for 30 minutes.

5.2.5 Wax Removal and Sintering
The solidified green bodies were then placed in a 75% ethanol solution at 70 °C to remove the
wax and for further solidification. After 10 minutes, the green bodies were then moved to an
oven for further wax removal and sintering. They were heated from RT to 700 °C at 1 ºC/min.
They were then held at 700 °C for 3 hrs before increasing to 1400 °C at 5 °C/min. They were
held here for 3 more hours before cooling to RT at 5 ºC/min.

Syringe

Slurry

Interconnected
Wax beads

Rubber
Stopper
Solidify green body in graded EtOH

Sinter: RT ‐> 700°C ‐>1400°C ‐> RT
1°C/min 3 hr 5°C/min 3 hr 5°C/min

Figure 5.3: Step by step method for fabrication of highly porous ceramic constructs
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5.2.6 Characterization
5.2.6.1 Macroscopic and SEM characterization
Porous scaffolds were characterized both macroscopically and with an SEM. Two different
SEMs were used: a Hitachi S4800 SEM and a JEOL LV-5610 SEM. There were used to evaluate
the shape, size, and pore structure of the porous scaffolds at an accelerating voltage of 20 kV and
a working distance of 20 mm. The pore structures were examined closely to determine
interconnectedness and pore size. Exact pore diameters were assessed using the SEM images and
ImagePro image analysis software.
5.2.6.2 Mechanical property and porosity measurements
The porous ceramic constructs were then evaluated to determine porosity and mechanical
properties. With all such scaffolds, an inverse relationship between of porosity and mechanical
properties was expected. We purposely fabricated the constructs to have a higher porosity, as this
is necessary for cell infiltration and bone ingrowth. For this reason, mechanical properties were
not expected to be high, but were still evaluated. First, porosity of the scaffolds was assessed. To
do so, we first determined the bulk density (ρbulk) of the scaffolds based on the scaffold volume
and weight. The material density (ρmaterial ) was also calculated for the ratio used based on known
values for density of βTCP and HA. This information was then used in the formula φ =1ρbulk/ρmaterial in order to determine the porosity. The mechanical properties of each of these
scaffolds were also determined, using a Shimadzu EZ graph universal testing machine. The
scaffolds were tested in compression using a 50N load cell at a rate of 2.5 mm/min. Based on the
scaffold shape and dimensions, force and displacement measurements were used to determine
the average ultimate stress of the scaffolds.
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5.2.7 In vitro cell studies
5.2.7.1 Cell attachment, migration, and morphology
Human embryonic palatal mesenchymal (HEPM) stem cells were seeded onto the porous
scaffolds in order to assess cell infiltration, migration, and morphology within the scaffolds.
HEPM cells were cultured until P4 and then passaged and seeded at a density of 5 x 103
cells/scaffold. To seed, the cells were suspended at a very high concentration in growth medium
(alpha minimum essential medium (αMEM) supplemented with 10% fetal bovine serum and 1%
antiobiotic) and dripped onto the scaffolds. After one hour, in which cells were allowed to
establish initial attachments to scaffolds, the scaffolds were completely covered with media
(about 1.5 mLs in a 12 well plate). The cells were allowed to culture on the 3D scaffolds for 7
days. They were then fixed with 4% Paraformaldehyde and stained with Phalloiding 488 for
actin (green) and 4',6-diamidino-2-phenylindole (DAPI) for the nucleus (blue). The scaffolds
were then dehydrated, embedded under vacuum overnight in LR White, and then sectioned using
a microtome. The sections were then floated onto glass slides and visualized using an Olympus
IX81 confocal microscope. Cell migration within the entire scaffold as well as cell morphology
was assessed.
5.2.7.2 Cell viability and proliferation
In order to assess scaffold toxicity as well as cell viability and proliferation, a cell titer blue assay
was performed. HEPM cells were cultured and seeded as described above. HEPM cells were also
cultured on biocoral®, a clinically available bone graft substitute, as a positive control. The cell
titer blue assay was performed on days 1, 3, 7, and 10. The day 1 analysis was performed after
allowing enough time to attach, yet before cells begin proliferating. This was done to determine
the ability for the cells to attach to the scaffolds. On the given days, the growth media was
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removed from the wells and was replaced with the cell titer blue reagent (5:1 growth media:Cell
titer blue). The cells were allowed to incubate in this reagent for 4 hrs. After 4 hrs, then reagent
was removed and saved. The cells were washed with additional media before replacing with the
media and incubating the cells at 37 °C and 5% CO2 until further use. The collected reagent was
pipetted into a 96 well plate in triplicates and the relative fluorescence intensity was measured
using a BioTek Synergy H1 Hybrid plate reader measured at an excitation of 560 nm and an
emission at 590 nm.

5.2.8 In vitro scaffold degradation study
The in vitro degradation of scaffolds was measured by soaking in PBS (pH 7.4, 37 ºC) for a
period of 28 days under constant shaking. Before soaking, and at various time points, the weight
of the scaffolds was measured. The scaffolds were dried at 80 °C for 1 day before measuring the
weight. From this data, the weight loss percentage over the time frame of the study would be
evaluated using the equation: weight loss = (Wi-Wf/Wi) x 100.

5.2.9 Statistics
All data presented are expressed as mean ± standard deviation (SD). Statistical analysis was
performed using the SPSS 15.0 software package (SPSS/PC Inc.) Data was analyzed using
Student’s t-test in order to determine a significance difference. Data was considered statistically
different if p≤ 0.05. n=4 was used for all studies unless otherwise indicated.
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5.3 Results

5.3.1 Characterization
5.3.1.1 Macroscopic and SEM characterization
Using the above described method, wax beads were fabricated that were from 200 µm to 1200
µm in size (Figure 5.4A). Various sizes were grouped using standard sieves for future use. For
this specific study, multiple sizes were tested while fabricating the porous scaffolds in order to
determine the beads size that would correlate with the desired final pore volume. It was
determined that the relationship between bead size and final pore size was 2:1 (data not shown).
Therefore, for this study, as pore sizes ranging from 400 µm to 600 µm was desired, wax beads
that were 800 µm to 1200 µm were used. To create a wax mold that would eventually create
interconnected pores in the green body, the wax beads were melted together for 5 minutes. Once
melted and cooled, the wax beads were formed into rigid structures. The union between various
wax beads can be seen in Figure 5.4B. These structures were then used as the porogen to create
the HA/βTCP ceramic constructs. Various sizes and shapes of the porous constructs were
fabricated, and could be tailored to specific defects, if necessary. Once sintered, these constructs
were observed and characterized. SEM images of representative scaffolds can be seen in
Figures 5.5A and 5.5B. From these images, not only can it be seen that the pore size was in the
desired range, but it can also be seen that the pores were highly interconnected. From the
macroscopic image in Figure 5.6, it is highly apparent how porous the scaffold is, in fact.
Though numerous other shapes and sizes were created, the representative scaffold depicted in
this image was approximately15 mm in length and 5 mm in diameter. In the future, the shape and
size of these scaffolds can be altered for in vivo studies and clinical use.
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5.3.1.2 Mechanical property and porosity measurements
The mechanical properties and porosity of the porous scaffolds was assessed to determine if they
were appropriate for use in non load bearing osseous defects. As porosity and mechanical
properties have an inverse relationship in these types of scaffolds, it was important to tailor its
properties to allow for the most bone regeneration. Based on this, we decided to create a
scaffold that was highly porous and allow for the maximum bone ingrowth, therefore sacrificing
the mechanical properties of the structures. However, these scaffolds could still be used in non
load bearing situations, and, in the future, the mechanical properties can be improved upon in
order to use for load bearing applications. Still, the mechanical properties were determined as a
reference point. As expected, the ultimate strength of the scaffolds was low, having an average
of 0.09 MPa. However, the scaffolds could still be easily handled without failure and would
easily be able to be implanted into a non load bearing defect without any trouble. On the other
hand, the porosity of the scaffolds was extremely high, demonstrating an average of 82.7%.
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Figure 5.7: Ultimate stress of scaffolds vs. porosity, showing inverse relationship
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5.3.2 In vitro cell studies
5.3.2.1 Cell attachment, migration, and morphology
Over a period of 7 days in culture, the HEPM cells demonstrated excellent attachment,
infiltration, and migration within the porous constructs. Once seeded onto the scaffold, the cells
attached at a very high rate to the scaffold, with minimal cells observed at the bottom of the well
(data not shown). Cells were fixed and stained with DAPI and Phalloidin 488 in order to observe
the cells within the scaffold post sectioning. In Figure 5.8, a representative image depicts the
cells throughout the entire thickness of the scaffold, showing that the cells were able to migrate
easily throughout. Further, it can be seen that the cells’ morphology is highly elongated and the
cells are present within the interconnected pores.

A

B

200 µm

200 µm

Figure 5.8: Confocal images depicting cell morphology and attachment (A) and demonstrating
the cells’ ability to migrate throughout the entire scaffold (B)

124

5.3.2.2 Cell Viability and Proliferation
HEPM cell viability was assessed on the scaffolds over a period of 10 days using a cell titer blue
assay. The highly porous scaffolds were compared to biocoral®, a clinically available bone graft
substitute, which was used as a positive control. After initial attachment, the cell titer blue
reagent was incubated with the cells for 4 hours on days 1, 3, 7, and 10. Similar data on day 1
suggests that cells attached just as well on the porous scaffolds as the controls. Significantly
enhanced cell numbers on days 3, 7, and 10 suggests enhanced viability and proliferation of the
preosteoblasts on the porous scaffolds, as compared to the control (Figure 5.9). This establishes
that the porous scaffolds are not only non-cytotoxic, but also confirms that these scaffolds
promote viability and proliferation of the cells, as the HEPM cells grew better on them than
clinically available controls.
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Figure 5.9: Cell viability of HEPM cells on the porous scaffold and a clinically available bone
graft substitute, biocoral®, over a period of 10 days, demonstrating enhanced viability and no
cytotoxicity of the porous scaffolds
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5.3.3 In vitro scaffold degradation study
The degradation of the scaffold was explored over 28 days. Scaffolds were weighed every 7
days and the percent weight loss over time was calculated. The scaffolds maintained their
structural integrity throughout the entire course of the study. It was determined, that on average,
the scaffolds degraded 25.15% over 28 days (Figure 5.10). This demonstrates a progressive
degradation rate that would correlate well with the regenerative rate of bone tissue, which is
known to take 3-6 months in vivo [45].
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Figure 5.10: Average degradation profile of porous ceramic scaffolds

5.4 Discussion
The clinical demand for an alternative treatment for critical sized bone defects is
immense. The shortcomings of current strategies are highly apparent, which include a lack of
donor tissue, donor site morbidity, infection, and the necessity of multiple surgeries [46-49]. To
alleviate these significant issues, tissue engineering strategies are now the focus of research for
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an alternative treatment of critical sized defects in bone. This strategy encompasses the use of
osteoprogenitor cells, along with engineered scaffolds and biomolecules, in order to regenerate
the afflicted tissue. Various approaches in this area have shown promise due to their ability to
avoid the major issues described above while actually regenerating the tissue instead of replacing
it. The basis behind these strategies is to regenerate new bone tissue that closely resembles the
native tissue in all aspects. To do so, many researchers are utilizing scaffolds that mimic the
structure and composition of the tissue in order to achieve this goal. For cancellous bone, this is
often accomplished by creating a highly porous ceramic construct that would allow for cell
infiltration and new tissue ingrowth. However, many factors come in to play when designing
such a scaffold, including the degree of porosity, mechanical properties, and degradation
kinetics, to name a few.
In this work, it was our objective to create a bone tissue engineering scaffold that mimics
the cancellous component of bone. This scaffold would be optimized and eventually paired with
a component that mimics that cortical component of bone in order to eventually test a truly
biomimetic scaffold in vivo for the ability to regenerate a tissue that is more similar to that of the
full structure of natural long bone. For this purpose, highly porous ceramic constructs that
mimic the structure and composition of cancellous bone were easily fabricated using the above
described methods. The size and shape of these scaffolds could be tailored to fit any bone type
and defect size. The scaffolds were fabricated with very high porosities in order to allow for
maximum cell infiltration and new tissue ingrowth. A specific ratio of components was utilized
in order to allow for degradation of the scaffold while maintaining decent mechanical properties.
The pore sizes of the fabricated porous ceramic scaffolds ranged from 300 to 500 µm.
These dimensions have been shown to be ideal for cell infiltration, new bone tissue ingrowth,
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and vascularization [28-30]. Further, from Figure 5.5B, it is highly evident that the pores are
highly interconnected throughout the scaffold. The interconnectedness of the scaffolds allowed
the osteoprogenitor cells to migrate throughout the entire scaffold. This is also very important
for new bone tissue to be able to grow and take over the space of the scaffold as it begins to
degrade. The overall porosity of the fabricated scaffolds was extremely high, exceeding an 82%
on average (Figure 5.7). This is considered pretty high for this application, as natural
cancellous bone has a porosity ranging from 50-90% and others typically only achieve porosities
averaging around 60-70% [29]. However, due to this high porosity, the mechanical properties of
the scaffold have suffered. The average ultimate strength of the scaffolds was 0.09 MPa. This
is significantly lower than the ultimate strength of cancellous bone, which is on average 1-6 MPa
[36-39]. Though the mechanical properties achieved are acceptable for non load bearing
applications, ongoing studies are being conducted in order to improve the mechanical properties
by altering the composition and fabrication method.
Preliminary in vitro studies indicated excellent attachment, infiltration, and migration of
osteoprogenitor cells within the entire scaffold (Figure 5.8). Further, the scaffolds exhibited a
significant enhancement of cell viability and proliferation after 10 days in vitro (Figure5.9)
when compared to clinically available bone graft substitutes. This demonstrates that the
scaffolds would be excellent candidates for bone tissue engineering applications. Ongoing
studies include altering the composition of the scaffolds in order to improve mechanical
properties as well as growth factor incorporation and release studies. Once optimized, the
scaffolds can be implanted in rabbit radial defects and assessed for bone regeneration capabilities
in vivo.
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5.5 Conclusion
In this study, highly porous ceramic constructs were fabricated for use in bone tissue
regeneration applications. The scaffolds exhibited a very high porosity, which allowed cells to
infiltrate and begin synthesizing new extracellular matrix. In the future, polymers can be
incorporated with these scaffolds to not only improve mechanical properties, but further mimic
the native structure of human long bone.
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CHAPTER 6
FABRICATING 3D BIOMIMETIC COMPOSITE SCAFFOLDS FOR LONG BONE
TISSUE ENGINEERING UTILIZING HIGHLY-ALIGNED BIOMINERALIZED
POLYMER NANOFIBERS AND HA/β-TCP POROUS CONSTRUCTS
6.1 Introduction
The distinct structure of human long bone is characterized by a central core of porous
cancellous bone encompassed by a shell of dense, organized cortical bone [1]. Each of these
components has different properties but together help bone perform its essential functions,
including structural support, protection, and growth factor/ mineral storage. The outstanding
performance of these functions, as well as the excellent properties of human long bone, is often
attributed to all the levels of the hierarchical organization of human bone, based upon the
underlying aligned collagen molecules and hydroxyapatite crystals [1]. Though this intricate
structure has enabled bone to be the strongest material in the body, defects still occur at an
alarming rate. When this tissue cannot heal on its own, surgical intervention must take place. As
there are many issues with current methods of treatment, researchers are now looking toward a
tissue engineering strategy for the regeneration of bone [2-15].
In order to fabricate a tissue engineering scaffold that is effective in regenerating the
designated tissue, it must possess numerous qualities. Most importantly, it must be able to
provide a framework which will allows cells to attach, migrate, and begin synthesizing new
extracellular matrix (ECM) [16-18]. To accomplish this goal, several properties are necessary,
including bioactivity, porosity, and biodegradability [19-21]. For a material to be bioactive, for
bone specifically, it must be able to interact with the bone forming cells as well as encourage
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bone ingrowth [22]. To achieve this goal, porosity and biodegradability are also very important,
as nonporous or non degradable materials would not allow new tissue to infiltrate the scaffold
[23]. Recently, on top of these necessary properties, researchers are currently trying to make
bone tissue engineering scaffolds biomimetic, as well, in order to more effectively regenerate the
tissue.
In order to make a biomimetic scaffold for bone regeneration, many researchers are
beginning to fabricate composites that are composed of both ceramics and polymers [24-28].
This is being done not only to mimic the actual microstructure of bone, but also to achieve
benefits and optimal properties from both components. For instance, ceramics are bioactive and
strong, but are often very brittle. On the other hand, polymers are ductile and versatile, but lack
strength [22]. By combining these two types of materials, one can create a product that has the
benefits of both components, while masking the flaws. There are many methods to fabricate
polymer/ceramic composites, which was introduced in chapter 2. Here, methods for
mineralizing polymer structures was described in depth, including simulated body fluid (SBF)
immersion [29-32], electrospraying [33-35], and co-precipitation methods [36, 37]. Other
approaches include the incorporation of polymer components within porous ceramic constructs
or vice versa [25, 26]. Neither of these methods is better than the other, and oftentimes a
particular method is chosen based solely on the application, desired structure that is being
mimicked, and properties required.
In this study, as our goal was to mimic the entire structure of human long bone, we aimed
to fabricate a 3D biomimetic tissue engineering scaffold for bone regeneration by combining the
use of mineralized, electrospun nanofibers and highly porous ceramic constructs. This structure
was successfully created by enveloping the porous ceramic construct with the mineralized
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nanofibrous arrays. This structure not only mimicked the structure of human long bone, but
possessed enhanced properties due to the inclusion of both polymer and ceramic components. In
the future, we aim to further enhance the mechanical properties of the structure by altering the
chemistry of the ceramic construct and incorporating polymer components within it. Once
optimized, growth factors can be included before testing the biomimetic scaffold in vivo to assess
bone regeneration capabilities and new tissue organization.

6.2 Materials and Methods

6.2.1

Materials

Paraffin was purchased from Leica Biosystems Richmond, Inc. (Richmond, IL). Polyvinyl
alcohol (PVA), β-Tricalcium phosphate (βTCP), polyethylenimine (PEI), sodium hydroxide
(NaOH), and Hydroxyapatite (HA), polycaprolactone (PCL) (MW 70,000-90,00), sodium
chloride (NaCl), sodium bicarbonate (NaHCO3), sodium sulfate (Na2SO4), potassium phosphate
dibasic trihydrate (K2HPO4·3H20 ), magnesium chloride hexahydrate (MgCl2·6H20 ) and calcium
chloride (CaCl2) were obtained from Sigma Aldrich (St. Louis, MO). Carbomethylcellulose
(CMC) was purchased from TCI Chemicals (Hong Kong, China). Ethanol (EtOH) was
purchased from Pharmco-Aaper (Brookfield, CT). Extra dry N, N-dimethylformamide (DMF)
was obtained from Alfa Aesar (Ward Hill, MA). Dichloromethane (DCM) was obtained from
Honeywell Burdick and Jackson (Muskegon, MI). Tris ((HOCH2)3CNH2) and sodium hydroxide
(NaOH) was obtained from Mallinckrodt Baker (Phillipsburg, NJ). Potassium chloride (KCl)
was obtained from Fisher Scientific (Chicago, IL). Hydrochloric acid (HCl) was obtained from
EMD Chemicals, Inc (Gibbstown, NJ).
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6.2.2

Fabricating individual components for the 3D biomimetic scaffolds
6.2.2.1Mineralized nanofibers arrays

Mineralized nanofiber arrays were fabricated as described previously (paper under review – see
chapter 3). Briefly, aligned PCL nanofibrous arrays with average fiber diameters of 0.66 ± 0.17
μm were fabricated via a conventional electrospinning approach. The surface of these nanofibers
were then modified by hydrolysis for 30 minutes and then mineralized for 24 hours using 5X
simulated body fluid (SBF). Individual mineralized arrays were then stacked on top of each
other with similar fiber orientations in order to create 3D, aligned nanofibrous scaffolds (see
Figure 6.1 for reconstruction of scaffold layers). Scaffolds of varying thicknesses could be
achieved. For this specific study, scaffolds with an average thickness of 1-2 mm were fabricated.
6.2.2.2 Porous ceramic constructs
Porous ceramic constructs were fabricated as described previously (paper under review – see
chapter 5). Briefly, a slurry of 85% β-Tricalcium phosphate (β-TCP) and 15% hydroxyapatite
(HA) was prepared and mixed for 24 hrs. During this time, was beads were produced via a
suspension method and were fabricated into a 3D cylindrical mold by melting together in a
cylindrical mold at 60 ºC for 5 minutes. A plunger was then used to impregnate the wax mold
with the slurry. The green body was allowed to solidify at room temperature for 30 minutes
before dehydrating in ethanol, heating to 60 ºC for 30 minutes for wax removal, and sintering.
For sintering, the green bodies were heated from RT to 700 °C at 1 ºC/min. They were then held
at 700 °C for 3 hrs before increasing to 1400C at 5 °C/min. They were held here for 3 more
hours before cooling to RT at 5 ºC/min.
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Figure 6.1: Amira image showing reconstruction of scaffold layers

6.2.3

Combining individual components into a single biomimetic construct for long bone

regeneration
The aligned, mineralized arrays and porous ceramic constructs were combined using a simple
rolling technique (see schematic in Figure 6.2) in order to create 3D biomimetic scaffolds that
fully mimicked the complete structure of human long bone. Briefly, the porous constructs were
placed on top of the stacked, mineralized, aligned nanofibers arrays. The fibers were then gently
rolled over the construct to completely encompass them. Depending on the thickness, the
nanofibrous arrays could be rolled over the porous constructs multiple times.

Figure 6.2: Schematic illustrating method for fabrication of 3D biomimetic scaffolds

138

6.2.4

Characterization

The 3D, biomimetic scaffolds were characterized in depth, macroscopically, with a microCT,
and with an SEM. For this study, a JEOL LV-5610 SEM and Scanco uCT40 microCT was used.
This equipment was used to visualize the shape, size, and mineralization of the structures.

6.2.5

Picrosirius red staining - Newly secreted ECM organization

Human embryonic palatal mesenchymal (HEPM) stem cells (ATCC) were seeded onto the 3D
mineralized nanofibers arrays and porous ceramic constructs in order to assess new ECM
production and organization. HEPM cells were cultured until P4 and then passaged and seeded
onto each scaffold at a density of 5 x 103 cells/scaffold. To do so, the cells were suspended at a
very high concentration in growth medium (alpha minimum essential medium (αMEM)
supplemented with 10% fetal bovine serum and 1% antiobiotic) and carefully dripped onto the
scaffolds. After one hour, in which cells were allowed to establish initial attachments to
scaffolds, the scaffolds were completely covered with media (about 1.5 mLs in a 12 well plate)
and maintained in an incubator at 37ºC with 5% CO2 . After 14 days in culture, the scaffolds
were immersed in a 0.1 % picrosirious red solution in saturated picrid acid for 1 hour. The
samples were then washed 2 times with acidified water. The samples were then visualized with
an Olympus light microscope and imaged using cellSens Dimension software. ECM organization
was assessed visually from the light microscopy images.

6.2.6

Statistics

All data presented are expressed as mean ± standard deviation (SD). Statistical analysis was
performed using the SPSS 15.0 software package (SPSS/PC Inc.) Data was analyzed using
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Student’s t-test in order to determine a significance difference. Data was considered statistically
different if p≤ 0.05. n=4 was used for all studies unless otherwise indicated.

6.3 Results

6.3.1 Characterization
Macroscopic images of the individual scaffold components, prior to combining, can be
seen in Figure 6.3(A and B) and Figure 6.4(B). Individual components could be produced with
varying dimensions, and could be tailored based on the application and bone type. Figure 6.3(C
and D) shows microCT images of the 3D mineralized nanofibrous arrays, demonstrating the
aligned mineralized components of the scaffold. Figure 6.3(D and E) shows picrosirius red
staining of the mineralized aligned nanofibrous arrays, demonstrating excessive collagen
formation on the arrays seeded with HEPM cells after 14 days in culture. Further, the secreted
collagen aligned along with the aligned nanofibers, demonstrating their ability to guide tissue
growth. From the SEM images of the porous scaffolds (Figure 6.4A), it can be seen that porosity
exceeds 80% and the pores are highly interconnected.
Fabricated biomimetic scaffolds mimicked the complete structure of long bone (Figure
6.5). The scaffolds could be tailored based on the application and bone to be regenerated. The
shape, overall length, overall width, and individual component thickness could be altered. For
this study, scaffolds with a length of 15 mm and overall width of 5 mm were fabricated. This
was done in order to fit a rabbit radial critical sized defect model, which we will use for future in
vivo studies. To achieve this width, the thickness of the mineralized nanofibrous arrays was 1
mm and the thickness of the porous ceramic scaffolds was 3 mm. When the nanofibrous arrays
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were wrapped around the porous ceramic constructs, the overall diameter (width) achieved was 5
mm. The interface between the two components can be seen from the SEM image in Figure 6.6.

Figure 6.3: Macrostructure (A and B) and MicroCT (C and D) images of 3D aligned
nanofibrous scaffolds, mimicking the cortical component of human long bone
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A

B

Figure 6.4: SEM image showing interconnected pore structure (A) and macrostructure (B)
image of highly porous ceramic constructs, mimicking the cancellous component of human long
bone

Figure 6.5: Macroscopic image depicting top view of 3D biomimetic scaffold (top portion is
uncovered to see porous ceramic interior)
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Figure 6.6: SEM image depicting longitudinal cross section of 3D biomimetic scaffold at
cancellous/cortical interface

6.3.2

Picrosirius red staining - Newly secreted ECM organization
Newly secreted collagen, which is stained by picrosirius red, can be seen in Figure 6.7.

Figure 6.7A and B depicts the cortical component of the scaffold, demonstrating that the
mineralized, aligned nanofibrous scaffolds guided new tissue growth, indicated by the aligned
collagen that can be seen in the images. Figure 6.7C depicts the cortical component, which
demonstrates that collagen was produced, though the organization was not assessed.
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Figuree 6.7: Picrosiirius red staiining of reprresentative aligned
a
nanoffibrous compponent, conttrol
with no cells (A) an
nd experimenntal (B), and porous canccellous compponent, conttrol with no cells
c
1 days in viitro, indicatinng newly forrmed ECM is
i being secrreted
(C) and experimentaal (D) after 14
and is being
b
guidedd by the biom
mimetic scaff
ffold

6.4 Discu
ussion
Inn this study, we successffully fabricatted 3D biom
mimetic constructs that mimicked
m
thee
entire strructure of hu
uman long boone. These scaffolds werre fabricatedd utilizing tw
wo different
componeents: minerallized, aligned nanofibrouus arrays andd highly porous ceramic constructs. The
mineralizzed, aligned nanofibrouss arrays weree wrapped arround the poorous ceramiic constructss to
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simulate the highly organized structure of cortical bone. The internal component, which has a
very similar composition and structure to cancellous bone, provided the structural framework of
the scaffold. To date, we are unaware of any existing scaffolds that so closely mimic this native
structure. In fact, other groups who claim to have fabricated “biomimetic” bone scaffolds often
are merely creating porous structures, sometimes containing both polymer and ceramic
components [38, 39]. As scaffold morphology has been shown to guide cellular and new ECM
organization [40-42], it was our goal in this study, to mimic the native structure of long bone
more closely in hopes of regenerating a tissue that is more similar to the native tissue. By
creating components the mimic both the cancellous and cortical components of long bone, we
believe that a more organized tissue will regenerate. This was further confirmed in our
preliminary studies, where new collagen produced aligned along the aligned nanofibers (Figure
6.3E and 6.3F) after 14 days in vivo.
In order to address two major concerns, our immediate goal is to incorporate star-shaped
microfibers within the 3D mineralized, aligned nanofibrous arrays to not only facilitate in
fabricating thicker scaffolds, but also prevent collapse upon implantation. Further, as
demonstrated in chapter 4, these fibers possess significantly greater surface areas and have been
shown to enhance cell attachment and proliferation. For these reasons, we believe that the
addition of the star-shaped microfibers would improve the 3D biomimetic scaffolds greatly.
Once the scaffolds are optimized, growth factors, such as bone morphogenetic protein 2
(BMP-2) and vascular endothelial growth factor (VEGF), will be incorporated by loading into
hydrogels and incorporating within the pores of the ceramic constructs. This will be done in
order to avoid a burst release and ensure the growth factors are present throughout the entire
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regeneration period. These scaffolds will then be implanted into rabbit radial critical sized
defects for a period of 12 weeks in order to assess bone regeneration and organization.

6.5 Conclusions
3D, biomemetic bone tissue engineering scaffolds were successfully fabricated in this
study. These scaffolds possessed multiple components that mimicked both the cortical and
cancellous components of human long bone. These scaffolds were characterized in depth.
Future studies include the incorporation of growth factors and implantation of these scaffolds in
vivo in order to assess their ability to regenerate bone as well as assess the organization of the
new bone tissue.
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CHAPTER 7
OVERALL CONCLUSIONS, CHALLENGES, AND FUTURE DIRECTIONS

7.1 Conclusions
The major impact of this work is the ability to more effectively regenerate bone tissue by
utilizing tissue engineering scaffolds that closely mimic the entire structure of human long bone.
By doing so, the scaffold will act as a template to guide new tissue growth to be more similar to
the native conformation. To fabricate these scaffolds, the very intricate structure of each
component of long bone was analyzed and mimicked using novel devices and methods designed
in our lab. Preliminary studies indicated that these scaffolds have excellent potential for uses in
bone tissue regeneration applications.
In chapter 3, the microstructure of lowest hierarchical level of cortical bone, aligned
collagen nanofibrils embedded with hydroxyapatite crystals, was mimicked utilizing mineralized
electrospun nanofibrous arrays. In this study, the correct parameters were determined in order to
get an optimal mineral coating on the surface of the nanofibers. A very distinct microstructure
was achieved which is unlike anything others have achieved to date. It was determined that
these mineralized arrays possessed excellent properties, including microstructure, mechanical
properties, and biocompatibility. Further, in vitro studies demonstrated that these scaffolds
promoted preosteoblast attachment, proliferation and differentiation, indicating they could serve
as excellent bone tissue engineering scaffolds.
Chapter 4 described an extension of the previous study, in which we attempted to mimic
the organized microstructure of cortical bone using star-shaped microfibers. The star-shaped
microfibers were fabricated using a novel extruding device designed in our lab. Fibers of various

151

shapes and sizes could be produced and tailored to fit specific applications. To our knowledge,
these types of intricately shaped fibers have not been investigated for tissue regeneration
applications. The superior surface area of these microfibers allowed for significantly enhanced
cell attachment and viability when compared to round controls. Further, we believe the aligned
nature and contact guidance provided by the grooves and microfibers will guide cell alignement
and new tissue organization. In the future, these fibers can be used in conjunction with other
tissue engineering techniques to aid in the fabrication of a biomimetic tissue engineering scaffold
with enhanced surface area and tissue regeneration capabilities.
In chapter 5, highly porous ceramic constructs were fabricated for use in bone tissue
regeneration applications. The scaffolds exhibited a very high porosity, exceeding 80%, which
allowed cells to infiltrate and begin synthesizing new extracellular matrix. Cell proliferation was
enhanced over 14 days when compared to a clinically available porous bone substitute,
indicating that these scaffolds would be an excellent candidate for use in bone regeneration
applications. Degradation studies indicated a steady degradation rate that would correspond with
new bone ingrowth. In the future, the composition can be altered and polymers can be
incorporated within these scaffolds to not only improve mechanical properties, but further mimic
the native structure of human long bone.
Finally, in chapter 6, biomimetic tissue engineering scaffolds mimicking the entire
structure of long bone were fabricated by combining the above mentioned techniques.

These

scaffolds were characterized in depth and demonstrated a macrostructure similar to human long
bone. Future studies include testing of the biomimetic scaffolds in rabbit critical sized radial
defects to assess new bone formation and organization.
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7.2 Challenges
Biomimetic bone tissue engineering scaffolds were successfully fabricated using novel
devices and methods designed in our lab. These scaffolds demonstrated very promising in vitro
results. However, many challenges occurred along the way, and still remain, before being able
to fabricate a clinically available biomimetic bone regeneration scaffold. In depth challenges are
summarized below by chapter.
In chapter 3, we discussed the fabrication of aligned nanofibrous arrays were successfully
fabricated via electrospinning and they were mineralized using simulated body fluid (SBF). The
major challenge to overcome when fabricating these scaffolds was determining the correct
parameters to create an optimal hydroxyapatite (HA) coating. This coating couldn’t be too thin,
too thick, or contain HA agglomerations. Even after these parameters were determined, issues
still arose, as any change in conditions could affect the coating. We believe the coating we
achieved was novel and contributed to the excellent properties of the scaffolds, so ensuring that
this structure was achieved every time was a must.
In chapter 4, the fabrication of star-shaped microfibers with desired qualities and
dimensions by using a novel extruding device designed in our lab was described. However, in
order to ensure that the appropriate dimensions were achieved, a major challenge was
determining the appropriate die size, collecting speed, and collecting distance. Once these
parameters were determined, uniform microfibers could be created. In the future, we are
anticipating a major challenge to be the construction of these microfibers into 3D structures in
order to use for the regeneration of various aligned tissues in the body.
Highly porous ceramic constructs that mimic the structure of human cancellous bone
were successfully fabricated and described in chapter 5. The major challenge when fabricating
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such a scaffold is balancing the appropriate amount of porosity and mechanical properties in
order to ensure that the scaffold can withstand physiological loads, but also allow for new tissue
ingrowth. As these properties exhibit an inverse relationship, it is often not feasible to have
desirable properties in both respects, and often have to choose. This was a major challenge for
us in this study. We elected to fabricate scaffolds that had over 80% porosity, as these have been
shown to enhance new tissue ingrowth, and therefore bone regeneration. For this reason,
however, the mechanical properties of the scaffolds were not optimal. They were significantly
less than those of human cancellous bone, which we would have liked to achieve. For this
reason, the current scaffolds can only be implanted in a non load bearing critical sized bone
defect. Future challenges include how to improve the mechanical properties of the scaffolds
without sacrificing the porosity or degradation rate.
Chapter 6 described our 3D biomimetic bone tissue engineering scaffolds, which were
successfully fabricated by utilizing both mineralized, aligned nanofibrous arrays and highly
porous ceramic constructs. These scaffolds mimicked the entire structure of human long bone.
In this study, a major challenge was the actual fabrication of these structures. The mineralized,
aligned nanofibrous arrays were about 1 µm in thickness, so in order to create a 3D structure that
was just 1 mm was very hard and required hundreds of layers. Oftentimes, a thicker scaffold
would be required, which would be very difficult to make. Another major issue, which would be
more of a challenge in the future, is that we noticed that the 3D nanofibrous structure would
collapse when put in contact with a liquid environment. This would create numerous issues
when conducting various in vitro experiments as well as when we implant the scaffolds in vivo.
These issues include change of shape/size, as well as possible issues with cell infiltration and
tissue ingrowth.
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7.3 Future goals
The ultimate goal of this project was to develop biomimetic bone tissue engineering
scaffolds in order to more effectively regenerate human long bone. The immediate goal would to
address the above challenges and improve the scaffolds. The fabricated scaffolds would then be
tested in vivo to validate their effectiveness and ensure the intended goal is achieved. In the long
run, other scaffold types can be derived from this work in order to regenerate various types of
tissues in the body. Future plans and goals are organized by chapter and summarized below.
In optimizing the scaffolds for the intended use, we must be able to create thick 3D
scaffolds utilizing the mineralized, aligned nanofibrous arrays. To do so, we believe that a
spacer would have to be incorporated between layers. Therefore, our next goal is to incorporate
star-shaped microfibers within the layers of the mineralized, aligned nanofibrous arrays in order
to create thick 3D scaffolds for bone tissue engineering applications. This would address two of
our challenges: the ability to create thick nanofibrous scaffolds as well as avoiding the collapse
of the 3D nanofibrous structures. Before incorporating these fibers, however, we would first like
to create a variety of shapes and sizes of the microfibers and assess surface area and perform
various in vitro experiments in order to assess cell attachment, alignment, and proliferation on
the fibers. The fibers that demonstrated the best results could then be used in the future for
various tissue engineering applications, including the 3D, biomimetic bone tissue engineering
scaffold.
As for the porous constructs, though we have achieved excellent porosity of these
scaffolds, the mechanical properties are still lacking. For this reason, our next goal is to improve
the mechanical properties of the scaffolds while still maintaining excellent porosity. To do so,
we will modify the chemistry by slightly changing the ratio of HA to β-Tricalcium Phosphate
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(βTCP). Also, we can alter the sintering temperature profile as well as slightly modify the
fabrication method in order to see if that has an effect on the mechanical properties. Once this is
complete the next major step is to incorporate growth factors, such as vascular endothelial
growth factor (VEGF) and bone morphogenetic protein 2 (BMP2), into hydrogels before housing
them in the pores of the ceramic constructs. In vitro release studies will then be performed in
order to ensure no burse release is experienced and that the growth factors release slowly over
the period of time it takes bone to regenerate.
Finally, one optimized, the ultimate goal of this project is to test the 3D biomimetic
scaffolds in vivo to assess the bone regenerative ability and bone organization. The challenges
listed above are being addressed currently, and we plan on conducting the in vivo experiments in
the near future. Initially, the scaffolds will be implanted in rabbit radial critical sized defects, but
can be implanted into larger animal models later, if necessary.
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